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Preface 
With the completion of ‘Human Genome Project’, we have in our hands a list of all human 
genes that define the blueprint of human life. These genes encode a variety of molecules which 
are responsible for biological processes like growth, division, movement, interaction etcetera. 
Acting alone or in groups, these biological macromolecules constitute a complex and intricate 
network that is turning out to be quite challenging for researchers to study. Scientists probe 
biological systems using a variety of techniques including genetics, bioinformatics, molecular 
biology, biochemistry work together to understand these complex biological systems. Here, I 
present a study involving techniques of structural biology and biophysics to understand 
molecular details. The reductionist method of dissecting biological systems into their constituent 
parts is the basis for the structural biology and biophysics and it has proven to be very effective 
in explaining the chemical basis of numerous living processes. One may argue about the ‘logical 
depth’ of reductionism and its use in finding structure based solutions to a biological problem 
(for example, drugs for a disease). This approach has given clear answers to several of the 
biological questions, especially those that address structure-function relationships. Keeping this 
in mind, here I present a study of ‘Structural basis of DNA binding complexes.’ 
Although, passage of information from DNA to Protein via RNA is considered as ‘central 
dogma’ of molecular biology, the field of epigenetics has emerged and has added a new 
dimension to this concept. In addition to the information encoded by the DNA sequence, distinct 
epigenetic mechanisms have evolved to store and propagate the information. DNA methylation, 
covalent and non-covalent histone modifications are a few examples of epigenetic regulation 
which are maintained by the action of epigenetic modifiers including DNA methyltransferase 
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(DNMTs), Histone methyltransferases (HMTs) and Histone deacetylases (HDACs). In mammalian 
cells, methylation occurs at the 5’ position of the cytosine from CpG dinucleotides. These 
methylated CpG islands are involved in transcriptional silencing of imprinted genes, genes 
located on the inactive X-chromosome, and a number of tumor suppressor genes. DNA 
methylation, as an epigenetic mark, is the main focus of this dissertation project. How this mark 
is ‘read’, the structural basis for ‘reader’ selectivity and how these ‘readers’ bring along other 
cellular machinery to carry out a task at hand are discussed in subsequent chapters with an 
appropriate example under study. 
The nucleosome remodeling and deacetylase (NuRD) complex is an abundant deacetylase 
complex, which couples histone deacetylation and chromatin remodeling ATPase activities, and 
has a broad cellular and tissue distribution. Although the working model of how this complex 
forms and functions is not well known, we have demonstrated that the coiled-coil interaction 
between two proteins (MBD2 and p66α) is critical for DNA methylation dependent gene 
silencing in vivo. Chapter one: ‘Unique features of the anti-parallel, heterodimeric coiled-coil 
interaction between methyl-cytosine binding domain 2 (MBD2) homologues and p66α dictate 
high affinity binding’ describes this unique coiled coil interaction. Coiled-coils were studied 
using a variety of biophysical techniques including analytical ultracentrifugation (AUC), 
isothermal titration calorimetry (ITC) and circular dichroism (CD). Results were compared 
across homologues and mutation studies were carried out to test our hypotheses. The studies 
reported in this chapter add to our understanding of coiled-coil interaction and thereby facilitate 
development of small peptide based drugs which target such interactions in nature. 
A number of proteins have been identified in humans that specifically bind to methylated 
CpG via a methyl binding domain (MBD). The human genome encodes at least five MBD 
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proteins: MeCP2 and MBD1 through MBD4, which are homologous in their methyl binding 
domains but not many similarities are seen outside the MBD. Out of the five MBDs, MBD4 has 
a c-terminal glycosylase domain through which it recognizes mCpG.TpG mismatch and is 
important for base excision repair system. Chapter two: ‘Dynamic behavior of MBD4 in 
methylated DNA recognition’ focuses on MBD4 and its preference for DNA methylation mark. 
Techniques of surface plasmon resonance (SPR), nuclear magnetic resonance (NMR) 
spectroscopy are used to study binding affinity for variations of methylated DNA mark. 
Chemical exchange studies are used to demonstrate how MBD4 scans for methylation mark and 
these studies have added a new dimension to our understanding of how MBD proteins ‘read’ 
DNA methylation marks. 
Chapter three: ‘Solving the solution structure of MBD domain of MBD4 on methylated 
DNA by NMR’ describes a process of structure determination using NMR spectroscopy. The 
focus of this chapter is not on developing a new technique but rather on using current resources 
to solve a protein structure, which can be used to further understand our biological system. Here, 
I have discussed the workflow used to determine a final three-dimensional structure starting from 
sample preparation, data collection, data analysis to structure calculation. 
I hope this dissertation project summarizing my work with DNA binding complexes 
provides some useful insights into understanding the complex field of epigenetic regulation.   
 
 
Chapter 1 
 
Unique features of the 
anti-parallel, 
heterodimeric coiled-coil 
interaction between 
methyl-cytosine binding 
domain 2 (MBD2) 
homologues and p66α 
dictate high affinity 
binding. 
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1.1 Abstract 
The methyl-cytosine binding domain 2 (MBD2)-nucleosome remodeling and deacetylase 
(NuRD) complex recognizes methylated DNA and silences expression of the associated genes 
through histone deacetylase and nucleosome remodeling functions.  Our previous structural work 
demonstrated that a coiled-coil interaction between the MBD2 and GATA zinc finger domain 
containing 2A (GATAD2A/p66α) proteins recruits the chromodomain helicase DNA-binding 
protein (CHD4/Mi2β) to the NuRD complex and is necessary for MBD2-mediated DNA 
methylation dependent gene silencing in vivo (1).  The p66-MBD2 interaction differs from most 
coiled-coils studied to date by forming a high-affinity anti-parallel heterodimeric complex 
between two peptides that are largely monomeric in isolation.  To further characterize the unique 
features of this complex that drive heterodimeric specificity and high affinity binding, we carried 
out biophysical analyses of MBD2 and related homologues MBD3, MBD3-like protein 
1(MBD3L1), and MBD3-like protein 2 (MBD3L2) as well as specific mutations that modify 
charge-charge interactions and helical propensity of the coiled-coil domains. Analytical 
ultracentrifugation analyses show that the individual peptides remain monomeric in isolation, 
even at 300 μM in concentration for MBD2. Circular dichroism analyses of the different 
mutations and homologues demonstrate a direct correlation between helical content of the coiled-
coil domains in isolation and binding affinity for p66. Furthermore, complementary 
electrostatic surface potentials and inherent helical content of each peptide are necessary to 
maintain high-affinity association. These factors lead to a binding affinity hierarchy of p66α for 
the different MBD2 homologues (MBD2 ≈ MBD3 > MBD3L1 ≈ MBD3L2) and suggest a 
hierarchical regulatory model in tissue and life cycle stage specific silencing by NuRD 
complexes. 
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1.2 Introduction 
1.2.1 DNA methylation as an epigenetic tool 
DNA methylation is the major modification of eukaryotic genome and is shown to be 
essential for development of mammals (2). DNA methylation involves methylation at the 5' 
position of symmetrically opposed cytosine bases in a double stranded cytosine-guanosine 
sequence (CpG). Clusters of CpGs, called CpG islands are GC rich regions of DNA with average 
length of 1kb and are often found associated with promoters and first exons of genes. The DNA 
methylation pattern of the CpG islands dictates the expression levels of the associated genes, 
methylation usually leads to repression (3, 4). In cancer, DNA methylation patterns are 
dramatically different, as there is a global decrease in CpG methylation but promoters of tumor 
suppresser genes become hypermethylated (5, 6). 
1.2.2 MBD2-NuRD complex 
At least five methyl-cytosine binding domain (MBD) proteins have been identified in 
humans, which share a homologous MBD that selectively binds methylated DNA: MeCP2 and 
MBD1 through MBD4. Each of these proteins contains a unique sequence outside of the MBD 
and recruit distinct co-regulatory complexes to silence expression of the associated gene, with 
the notable exception of MBD2 and MBD3 which share > 65% identity (5, 7-10).  The 
nucleosome remodeling and deacetylase (NuRD) complex is an abundant deacetylase complex 
with a broad cellular and tissue distribution. MBD2 and MBD3 recruit NuRD which couples 
histone deacetylation and chromatin remodeling ATPase activities in the same complex. The 
working model of how this complex forms and functions is unknown. In MBD2 containing 
NuRD complexes, MBD2 binds methylated DNA selectively and is responsible for recruiting the 
4 
 
NuRD complex to methylated CpG islands. On the other hand, mammalian MBD3 does not 
specifically recognize methylated DNA and MBD3-NuRD complexes are not preferentially 
associated with methylated CpG islands. The core components of the NuRD complex include 
Mi2α/β, HDAC1 and 2, RbAp46/48, MTA1/2, p66α/β, and MBD2 or MBD3 (Figure 1.1A). 
Information about all components is summarized in Table 1.1.  
1.2.3 Domain organization of MBD2 and p66α  
MBD2 mRNA can be read to give two isoforms, MBD2a and MBD2b. MBD2b shares high 
degree of homology with MBD3, whereas MBD2a has an additional N-terminal 140 amino acids 
which has several glycine-arginine rich repeats; the function of which is unknown (11). Human 
MBD2b is  262 amino acid long and has two distinct domains: N-terminal MBD, which binds to 
methylated DNA (12) and C-terminal coiled coil which has been shown to interact with p66α (1). 
The p66α/β subunits from NuRD are 66kDa transcriptional repressors that interact directly with 
MBD2, MBD3, and histones (13-15). p66α has a N-terminal conserved region (CR1) that covers 
a coiled coil domain and a C-terminus conserved region (CR2) that has a GATA like zinc finger 
domain. Domain organization of MBD2 and p66α are shown in Figure 1.1B and 1.1C, 
respectively.
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Figure 1.1: Components of MBD2-NuRD. A) Schematic representation of the MBD2-
NuRD complex. B) Domain organization of MBD2b: MBD is methyl binding domain; 
CC is coiled-coil domain C) Domain organization of p66α: two conserved regions are 
seen. CR1 is a coiled coil domain; CR2 includes a GATA zinc finger domain. 
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Table 1.1: Summary of MBD2-NuRD complex components. 
 
Protein Function Conserved Domains 
Mi2α/β (CHD3/CHD4) 
large multi-domain protein with a 
central helicase-like ATPase that 
functions in chromatin remodeling 
SNF2_N (DEXHc), 
HELICc, CHDN, PHD, 
CHROMO, CHDCT2, 
DUF 
HDAC1/2 histone deacetylase enzyme HDAC 
RbAp46/48 
(RBBP7/RBBP4) 
bind HDACs and histone tails and 
facilitate deacetylase activity 
WD40 
MTA1/ 2 
associated with histone as well as 
non-histone deacetylase complexes 
BAH, ELM2, SANT, 
GATA zinc finger 
p66α/β (GATAD2A/B) bind MBD2 and histones 
Coiled-coil, GATA zinc 
finger 
MBD2 binds methylated CpG MBD and coiled-coil 
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1.2.4 Pivotal role of MBD2-p66α interaction in MBD2 mediated silencing  
MBD2 is associated with repression of several genes. For example, repression of chicken 
ρ-globin expression is under control of MBD2 mediated silencing. siRNA knock-down of 
chicken MBD2 leads to a 25-fold increase in ρ-globin expression. Knockout of the MBD2 gene 
in βYAC transgenic mice leads to persistent γ-globin expression in the adult mouse (16, 17). 
Coiled coil interaction between MBD2 and p66α is central to formation of functional NuRD 
complex. We recently demonstrated that the highly conserved and homologous C-terminal 
coiled-coil regions of MBD2 and MBD3 form a high-affinity heterodimeric complex with p66 
critical for recruitment of the Mi2 protein and methylation dependent gene silencing in vivo. 
Also, enforced expression of the isolated p66α coiled-coil domain relieves MBD2-mediated 
globin gene silencing and the expressed peptide interacts only with a subset of components of the 
MBD2-NuRD complex that does not include native p66α or Mi-2. These results demonstrate the 
central importance of the coiled-coil interaction and suggest that MBD2-dependent DNA 
methylation-driven gene silencing can be disrupted by selectively targeting this coiled-coil 
complex (1). 
1.2.5 Coiled-coil: a common structural motif  in nature 
The coiled-coil domain represents a relatively simple yet common protein:protein 
interaction motif found in as many as 10% of all eukaryotic proteins (18).  Recent work has 
shown that selective disruption of coiled-coil complexes can target specific protein complexes 
for potential therapeutic benefit (1, 19). Coiled-coils form specific homo or hetero-oligomeric 
complexes involving 2-7 α-helices in parallel or anti-parallel arrangements important for a wide 
variety of cellular functions either on their own or as a part of larger protein complexes (18, 20-
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22).   Most studies to date have described the formation of parallel homo-oligomeric coiled-coils 
while the anti-parallel heterodimeric coiled-coil complexes are relatively understudied (19, 22). 
Note that coiled-coil interaction between MBD2 and p66α is heterodimeric and anti-parallel thus 
relatively understudied. A coiled-coil domain can be identified by a regular seven amino acid (a-
g) repeat of hydrophobic and charged residues. In this heptad repeat, a branched hydrophobic 
residue is present at a and d positions while charged/polar residues are present at e and g. These 
seven residues form approximately two turns of a typical α-helix, generating a hydrophobic face 
(a and d) bordered by charged/polar residues (e and g). Two or more of these α-helices bind 
along this hydrophobic interface and, due to the natural rotation of this surface, the helices tend 
to wrap around one another forming a ‘coil of coils.’ This arrangement is capable of forming 
either parallel or anti-parallel hetero- or homo-oligomeric complexes ranging from 2 to 7 helices. 
Despite this seemingly simple paradigm, subtle variations in sequence can have dramatic 
consequences on binding specificity, stoichiometry, and parallel vs. anti-parallel alignment (23). 
1.2.6 Coiled-coils of MBD2, p66α and homologues of MBD2  
Out of family of five MBD binding proteins, MBD2 and MBD3 are the only proteins with 
a coiled-coil domain which is approximately 34 amino acids long. There are two other proteins, 
MBD3-like protein 1 (MBD3L1) and MBD3-like protein 2 (MBD3L2) which contain 
homologous coiled-coil domain but lack the methyl-CpG-binding domain. MBD3L1 and 
MBD3L2 have been shown to be capable of recruiting an intact NuRD complex.  MBD3L2 is 
expressed in germ cell tumors and some somatic tissues while MBD3L1 is testis specific and 
expressed in post-meiotic spermatids (24-26). The coiled-coil of p66α is approximately 41 amino 
acids long and binds in anti-parellel fashion to MBD2 homologues. Domains organization of 
coiled coils of MBD2 homologues is depicted in Figure 1.2A. In Figure 1.2B shows sequence 
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alignment and the key residues that are involved in making hydrophobic and polar/ionic 
interactions with the coiled-coil of p66 are highlighted. Given the similarities and differences 
between these homologous domains, we have pursued detailed analysis of the different 
homologues to gain a better understanding of the structural determinants for high affinity 
binding. 
In the studies presented here, we show that high affinity binding requires pre-formed 
helical content as well as specific charged residues on the individual coiled-coil domains. The 
reduction in helical content of the isolated MBD3L1 and MBD3L2 homologues reduces binding 
affinity for p66. We previously demonstrated that changing the charge of three residues in 
p66 eliminates binding to wild type MBD2 (1). Introducing complementary charge changes in 
MBD2 restores binding, but not with the same high affinity as wild type. Based on electrostatic 
potential calculations, we suggest that the uniquely high affinity association of the wild type 
complex depends on complementary alternating positive and negative electrostatic potential 
surfaces. Hence variations in both the helical content and electrostatic interactions between 
MBD2 homologues lead to a relative binding affinity hierarchy for p66 (MBD2 ≈ MBD3 > 
MBD3L1 ≈ MBD3L2). 
10 
 
 
 
 
Figure 1.2: The coiled-coil interaction between MBD2 homologues and p66α: The 
domain organization (A) is diagramed for MBD2 and homologues, which shows that the 
MBD3L1 and MBD3L2 proteins lack a methyl-cytosine binding domain. A sequence 
alignment (B) of the coiled-coil (cc) domains from p66α and MBD2 homologues is 
shown with key hydrophobic (yellow) and ionic/polar (cyan) contact residues highlighted 
and the heptad repeat (a-g) indicated above the amino acid sequences. A helical wheel 
diagram of the complex (C) highlights the interacting residues at positions a, d, g, and e 
of the heptad repeat with key charged residues circled in red. A ribbon diagram of the 
p66α-MBD2 coiled-coil complex (D) is shown with the branched hydrophobic residues at 
the a position on each chain depicted as spheres and the two central glutamates (E155 
and E156) of p66α depicted as sticks. 
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1.3 Materials and methods 
1.3.1 Protein expression and purification  
The coiled-coil regions of human MBD2b (amino acids 211-244), MBD3 (amino acids 
216-249), MBD3L1 (amino acids 145-178), MBD3L2 (amino acids 166-199) and p66α (amino 
acids 138-178) were cloned and expressed with a hexahistidine tag and as thioredoxin fusion 
proteins in a modified pET32a vector (27). The expression vectors were transformed into the 
BL21(DE3) E. coli strain, grown in Luria Bertani medium at 37 
0
C and induced with 1 mM 
isopropyl-β-d-thiogalactopyranoside at an A600 ~ 0.8. The bacteria were harvested after 2 hours 
of induction and lysed with the B-PER reagent (Thermo Scientific). The soluble fraction was 
passed over a nickel-sepharose column, protein eluted with a step gradient of imidazole and 
further purified by gel filtration over a Superdex-75 column (GE Healthcare).  The thioredoxin 
fusion proteins were used directly for analytical ultracentrifugation (AUC) and isothermal 
titration calorimetry (ITC) studies. For circular dichroism (CD) studies, clones were modified to 
incorporate a tyrosine residue just after the thrombin cleavage site (for quantification of the 
isolated peptide by UV) and were expressed in a similar manner.  After purification over a 
nickel-sepharose column, the peptides were cleaved by thrombin digest and isolated by gel 
filtration chromatography over a Superdex-75 column (GE Healthcare).  Specific mutations were 
introduced using the QuickChange® site-directed mutagenesis kit (Stratagene) following the 
manufacturer’s protocol.  The final concentrations of all protein samples were determined by UV 
absorbance at 280 nm.  
1.3.2 Analytical ultracentrifugation  
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Sedimentation velocity experiments were carried out using a Beckman Optima XL-I 
analytical ultracentrifuge (Beckman Coulter Inc.) equipped with a four and eight-position AN-
60Ti rotor. Sedimentation was performed at 40,000 rpm, 20 ºC, under physiological buffer 
conditions (20 mM Tris pH 8.0, 150 mM NaCl). Sedimentation profiles were recorded using UV 
absorption (280 nm) and interference scanning optics.  The partial specific volume (V¯ ) of the 
sample, density (ρ) and viscosity (η) of the buffer were calculated using the SEDNTERP 
program (28). Data were fit using a continuous size distribution (c(s)) and the effective molecular 
weight determined from the resulting sedimentation coefficients with the SEDFIT software (29). 
1.3.3 Isothermal titration calorimetry 
Protein samples were prepared in standard buffer (20 mM Tris pH 8.0, 150mM NaCl) and 
binding analyzed with an iTC200 Microcalorimeter (GE Healthcare).  A total of 24 injections (1.5 
µL each) of the p66α coiled-coil (100 µM) were injected into MBD2 and homologues (10 µM, 
298 K, stir speed of 400 rpm, 120 seconds time delay between injections). The resulting 
isotherms were auto adjusted for baseline and fit to a one-site binding model using Origin 7.0 
software to determine binding constant (KD , Ka
-1) and enthalpy (ΔH) while the Gibbs free 
energy (ΔG) and entropy (ΔS) of binding were calculated according to Equation 1.1, 
                                               −RTln(K) = ΔG = ΔH – TΔS                        (Equation 1.1) 
where T is the temperature in Kelvin and R is the gas constant. 
1.3.4 Circular dichroism 
CD spectra were collected on purified peptide samples (~33 g/mL total protein in 10mM 
sodium phosphate, pH 6.5) with a JASCO J-715 CD spectrometer (JASCO Corp) at 293 K, with 
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a 1 cm path length, scanning from 190-260 nm with 0.5 nm interval at a scanning speed of 50 
nm/min. CD spectra were normalized to give molar ellipticity values (θ) in degrees·cm-2·dmol-
1
residue
-1.  Helical content for each peptide was calculated from the ratio of the observed θ222nm 
to the expected θ222nm for 100% helix as given by 40,000 × [(n − 4)/n], where n is the number of 
residues (30). Thermal denaturation was followed at θ222nm from 277-368K at 1 K intervals with a 
heating rate of 1 K/min. The data were fit to a simple two state thermodynamic model of 
unfolding as described by Koepf et al. (31) . 
1.3.5 Helical content prediction 
The expected helical content for each peptide was calculated using the AGADIR (32, 33) 
algorithm with the N- and C-termini ‘free’, at 293 K, ionic strength of 0.02, and pH 6.5 to closely 
match the experimental conditions for CD.  The predicted helical content was used to help design 
amino acid changes that stabilize helix formation. 
1.3.6 Electrostatic surface potential 
The coordinates of the isolated wild type coiled-coil domains were extracted from the 
previously determine solution structure (PDB# 2L2L) and the surface potential calculated with 
the Adaptive Poisson-Boltzmann Solver (APBS) (34).  The coiled-coil domains of the different 
mutants and homologous domains were derived from the wild type MBD2 structure by 
introducing appropriate sequence differences with the mutagenesis function of PyMOL (35) and 
choosing a sidechain rotamer that did not sterically collide with neighboring residues. The 
calculated electrostatic potential was mapped to the solvent accessible surface with the APBS 
plugin tool in PyMOL and colored from red to blue (-1 eV to +1 eV, respectively). 
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1.4 Results 
1.4.1 Key contact residues are conserved among MBD2 homologues 
The key contact residues in the MBD2 coiled-coil domain are conserved across all 
homologues, with MBD3L2 composed of the most divergent sequence (44% identity between 
MBD2 and MBD3L2 coiled-coil domains), whereas MBD3 and MBD2 are nearly identical (93%  
identity). Anti-parallel coiled-coils form sequential intermolecular interactions between branched 
hydrophobic residues at a and a’ as well as d and d’ positions of the heptad repeat in the two 
chains. Recent work indicates that select triplet repeats at the a’-a-a’ positions favor 
heterodimeric coiled-coil formation, with LIL or ILI triplets the most favored combination (36). 
As can be seen in Figure 1.2, the a positions are identical across all MBD2 homologues with the 
a-a’ interactions composed by RILVLLI (p66α residues are in italics throughout). This 
arrangement includes two favorable I-L pairings and one of the more favorable triplets, LVL. 
The highly conserved valine residue of this triplet inserts into a pocket between two conserved 
glutamate residues at a central bend in the p66α helix (Figure 1.2D). The shorter valine side 
chain (as compared with isoleucine and leucine residues) allows close approximation of the two 
helices, which likely contributes to close intermolecular ionic interactions involving the 
glutamate residues. The conserved d-d’ interactions (37), which are composed of LQEV(A)LA, 
also place a valine (or alanine in MBD3L2) at the bend on the p66α helix near these same 
glutamate residues. 
1.4.2 Coiled-coils of MBD2, MBD3, MBD3L1 and MBD3L2 are largely monomeric in 
isolation 
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Although coiled-coil domains often form homo-oligomeric interactions, we previously 
demonstrated that both MBD2 and p66α remain monomeric in isolation (1). To test for homo-
oligomerizaton of the different homologues as well as the concentration dependence of 
homodimerization of MBD2 and p66α, we carried out sedimentation velocity AUC studies. The 
MBD2 coiled-coil domain remains monomeric even at concentrations up to 300 μM (Figure 
1.3A). On the other hand, the p66α coiled-coil shows a tendency to form a homodimer at 
concentration beyond 50 μM (Figure 1.3B); however, the monomer remains the dominant 
species up to 300 μM. Given the low nanomolar binding constant between MBD2 and p66α 
coiled-coil domains, p66α preferentially forms a stable heterodimer with MBD2 rather than a 
homodimer. Similarly, AUC analyses showed that the coiledcoil domains of MBD3, MBD3L1, 
and MBD3L2 homologues remain stable monomers at 50 μM concentrations (Figure 1.3C). 
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Figure 1.3: The coiled-coil domains remain largely monomeric in isolation. Analytical 
ultracentrifugation analysis was performed on the individual coil domains and the 
sedimentation velocity fit using a continuous size distribution (c(s)). The results are 
shown for increasing concentrations of MBD2 (A) and p66α (B) coiled-coil domains as 
well as for 50 μM concentrations of the coiled-coil domains from MBD3, MBD3L1, and 
MBD3L2 (C) and MBD2 and p66α mutants (D). 
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1.4.3 Binding analysis of MBD2 homologues reveals a hierarchial affinity 
preference for the p66α coiled-coil 
ITC was performed using thioredoxin fusion constructs of the coiled-coil domains. 
Exothermic heat was generated with each injection in all experiments. The binding isotherms are 
shown in Figure 1.4, and the measured binding affinity (KD), free energy (∆G), enthalpy (∆H), 
and entropy (-T∆S) for each homologue is provided in Table 1.2. These results show that p66α 
binds with higher affinity to MBD3 (KD = 23 ± 3 nM) and MBD2 (KD = 42 ± 9 nM) as compared 
with MBD3L1 (KD = 377 ± 34 nM) and MBD3L2 (KD = 268 ± 32 nM). Each complex binds 
with a stoichiometry of ~ 1:1 (n ranges from 0.7 to 1.4, Table 1.2) consistent with heterodimer 
formation. The reduced binding affinity of p66α for the MBD3L1 and MBD3L2 homologues 
reflects a more unfavorable change in entropy upon binding (-T∆S = 0.17 and 6.3 kcal/mol for 
MBD2 and MBD3L1, respectively) that is not fully compensated by a more favorable change in 
enthalpy (∆H = -10.2 and -15.1 kcal/mol for MBD2 and MBD3L1, respectively). 
Although the coiled-coil domains do not contain a histidine residue or other titratable 
protons at a pH of 8.0, the high ionization enthalpy of Tris buffer (11.4 kcal/mol) (38) could 
contribute to the apparent enthalpy change upon binding. To address this possibility, we repeated 
ITC for MBD2-p66α in PIPES buffer (20 mM  PIPES, pH 7.5, 150mM NaCl), which has a much 
lower ionization enthalpy (2.7 kcal/mol) (38). The binding constant and change in enthalpy are 
very similar in PIPES (KD = 30 ± 11 nM, ∆H = -10.8 ± 0.2 kcal/mol, -T∆S = 0.56 kcal/mol), 
which indicates that complex formation does not involve net transfer of a proton. 
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Figure 1.4: Binding analysis of MBD2 homologues. Isothermal titration calorimetry 
studies were performed and the experimental data (top panel) and resulting fit (bottom 
panel) are shown for MBD2, MBD3, MBD3L1, and MBD3L2 coiled-coil domains 
binding to the p66α coiled-coil domain.  
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Table 1.2: Binding affinity analyses. The dissociation constant (KD), change in enthalpy (∆H), 
entropy (-T∆S), Gibbs free energy (∆G), and apparent stoichiometry (n) derived from isothermal 
titration calorimetry studies are given for wild type and mutant coiled-coil complexes between 
p66α and MBD2 homologues.  
 
Coiled-coil complex n 
KD 
(nM) 
∆H 
(kcal/mol) 
-T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
MBD2/p66α 1.1 42 ± 9 -10.2 ± 0.1 0.17 -10.0 ± 0.1 
MBD3/p66α 1.4 23 ± 3 -10.8 ± 0.1 0.35 -10.4 ± 0.1 
MBD3L1/p66α 0.9 377 ± 34 -15.1 ± 0.2 6.3 -8.8 ± 0.1 
MBD3L2/p66α 1.4 268 ± 32 -14.7 ± 0.2 5.7 -9.0 ± 0.2 
MBD2(REE)/p66α(RRE) 0.7 10,800 ± 400 -27.1 ± 0.4 20.3 -6.8 ± 0.4 
MBD2(REE)/p66α(RRD) 1.2 38,000 ± 2000 -13.9 ± 1.1 7.9 -6.0 ± 1.1 
MBD2(REER)/p66α(RRE) 0.8 5,400 ± 500 -20.0 ± 0.7 12.8 -7.2 ± 0.7 
MBD2(REER)/p66α(RRD) 0.7 33,000 ± 9800 -16.3 ± 1.1 10.2 -6.1 ± 1.1 
MBD2(E225G)/p66α  ≥ 50,000 
   
MBD3L1(G159E)/p66α 1.3 44 ± 20 -22.2 ± 0.5 12.2 -10.0 ± 0.5 
 
 
 
 
 
 
 
 
20 
 
1.4.4 High affinity binding depends on the helical content of the isolated coiled -
coil domains 
We previously demonstrated that the MBD2 and p66α coiled-coil domains show a strong 
tendency to form monomeric helices in isolation (1). An algorithm based on helix-coil transition 
theory (AGADIR (32, 33)) predicts that the MBD3L1 and MBD3L2 homologues do not have the 
same tendency to form α-helices in isolation (Table 1.3). CD analyses were performed on the 
isolated domains, which confirmed the relative helical content of the homologous coiled-coil 
domains in isolation. MBD2 (25%) and MBD3 (28%) are more helical than MBD3L1 (7%) and 
MBD3L2 (11%) (Figure 1.5A). The thermal stability of the different coiled-coil complexes was 
determined by following molar ellipticity at 222 nm (θ222 nm) as a function of temperature. 
Complexes involving MBD2 and MBD3 melt at a higher temperature than those involving 
MBD3L1 and MBD3L2, consistent with the higher binding affinities of MBD2 and MBD3.  
To test whether helical content dictates high affinity association, we introduced mutations 
at residues opposite the binding interface of the coiled-coil domains of MBD2 and MBD3L1 that 
reduce or increase helical content, respectively. A glycine for glutamate substitution in the 
middle of the helix opposite the binding interface could contribute to the reduced helical content 
of MBD3L1 (Figure 1.5B). Consistent with in silico calculations, the G159E mutation of 
MBD3L1 increases helical content (7% to 16%, Table 1.3), whereas the E225G mutation of 
MBD2 reduces helical content (25% to 9%, Table 1.3). As expected, the binding affinity for the 
p66α coiled-coil domain (Table 1.2) and the melting temperature of the complex (Table 1.4) 
increased for MBD3L1 G159E (KD  = 44 nM, Tm = 331 K), which is close to the affinity of wild-
type MBD2 (KD = 42 nM, Tm = 338 K) and much greater than wild-type MBD3L1 (KD = 377 
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nM, Tm = 319 K). In contrast, the binding affinity and melting temperature of MBD2 E225G (KD 
> 50 µM, Tm = 313 K) was greatly decreased as compared with wild type. Because this residue is 
on the side of the helix opposite the binding surface and does not directly interact with p66α, 
these findings support the hypothesis that high affinity association requires pre-existing helical 
content. 
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Figure 1.5: The helical content and thermal denaturation of MBD2 homologues. Circular 
dichroism spectra (A) of the coiled-coil domains from MBD2 homologues in isolation are 
shown and labeled with the helical content as calculated from θ222nm. The temperature 
dependence of θ222nm (B) is shown from 277 to 368 K for coiled-coil complexes between 
the MBD2 homologues and p66α. The data were fit to a simple two-state unfolding 
model (31), and the resulting thermal denaturation curves labeled with the melting 
temperature (Tm). 
23 
 
Table 1.3: Helical contents of the isolated coiled-coil domains. The percent helix as predicted by 
AGADIR and calculated from the circular dichroism molar ellipticity at 222 nm (θ222 nm) is given 
for the wild type and mutant coiled-coil domains. 
Coiled-coil domain 
Helical propensity in isolation 
Predicted* (%) Calculated** (%) 
MBD2 39.5 24.6 
MBD3 48.0 28.3 
MBD3L1 11.2 6.7 
MBD3L2 7.5 10.7 
MBD2(E225G) 11.1 8.9 
MBD3L1(G159E) 24.8 15.5 
MBD2(REE) 7.0 9.1 
MBD2(REEE) 20.6 35.8 
P66 55.3 66.0 
P66(RRE) 56.1 59.6 
*Based on AGADIR algorithm 
**Based on circular dichroism measurements 
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Table 1.4: Thermal stability of the complexes. The melting temperatures (Tm) derived from 
circular dichroism studies are given for wild type and mutant coiled-coil complexes between 
p66α and MBD2 homologues. 
 
Coiled-coil complex Tm (K) 
MBD2/p66α 338 
MBD3/p66α 332 
MBD3L1/p66α 319 
MBD3L2/p66α 308 
MBD3L1(G159E)/p66α 331 
 
  
25 
 
1.4.5 Specific ionic interactions are required for high affinit y coiled-coil complex 
formation 
We recently demonstrated that mutating specific charged residues of p66α reduces binding 
affinity by 3 orders of magnitude when introduced separately (either E155R/E156R or R166E) 
and abolishes complex formation when introduced together (E155R/E156R/R166E)(1).These 
residues form close ionic interactions with three charged residues in MBD2 (Asp-217, Arg-226, 
and Arg-231) that are conserved across all MBD2 homologues (Figure 1.2B) and likely provide 
specificity for the coiled-coil interaction. Based on this observation, we hypothesized that 
introducing complementary changes in MBD2 would restore high affinity binding. 
Introducing the D217R/R226E/R231E mutations in MBD2 (MBD2(REE)) does restore 
binding to the and p66α E155R/E156R/R166E mutant (p66α(RRE)). However, ITC analysis 
(Figure 1.6) indicates a much lower affinity between the mutant proteins (KD = 10.8 µM) than 
wild type. In silico calculations with AGADIR as well as CD measurements show that mutating 
these residues decreased the α-helical content of MBD2 (9% versus 25%, Table 1.3). These 
changes introduced an unfavorable charge interaction between Glu-231 and Glu-235 residues of 
MBD2(REE). To increase helicity, a fourth mutation (E235R) was introduced (as predicted by 
AGADIR) without disrupting intermolecular contacts. The D217R/R226E/R231E/E235R mutant 
MBD2 (MBD2(REER)) did show an increase in helical content (36% versus 9%, Table 1.3), and 
ITC revealed a slight increase in binding affinity (5.4 µM) for p66α(RRE) as compared with 
MBD2(REE) but still approximately 2 orders of magnitude lower than for the wild type 
complex. 
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One potential difference between the wild type and mutant complexes is that the favorable 
Arg-166-Asp-217 p66α-MBD2 ionic interaction was replaced by Glu-166-Arg-217 in the mutant 
complex. The additional carbon atom in glutamate (as compared with aspartate) could alter the 
geometry and prohibit favorable interaction. However, both MBD2(REE) and MBD2(REER) 
bound to p66α(RRD) with lower affinity than p66α(RRE) (Table 1.2), demonstrating that this 
difference was not responsible for the lower binding affinity. 
Alternatively, swapping glutamate and arginine residues between chains could alter the 
geometric relationship between the charged residues by changing the relative positions of the 
two residues on the helical backbone. Changes in the relative positions of these residues could 
preclude ideal interaction and prevent high affinity association. Geometrical restraints are 
particularly important for hydrogen bond formation. Hence, to probe this possibility we tested 
whether geometrically restrained bidentate hydrogen bonds could be formed between the p66α-
MBD2 intermolecular ionic pairs of Arg-166-Asp-217 or Glu-156-Arg-231 and the respective 
charge swap mutations. We introduced hydrogen bond distance and angle restraints and 
performed simulating annealing calculations (XPLOR_NIH (39)) while keeping the coordinates 
fixed for all backbone atoms and the side-chain atoms for all amino acids exclusive of the four 
under consideration. As can be seen in Figure 1.7, reasonable hydrogen-bond distances and 
angles can be established between these side chains in both the wild type and mutant complexes, 
suggesting that geometric constraints do not prevent optimal interaction in either case. 
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Figure 1.6: Binding analyses of mutants of MBD2 and MBD3L1. Isothermal titration 
calorimetry studies were performed and the experimental data (top panel) and resulting 
fit (bottom panel) are shown for the coiled-coil domains of MBD3L1(G159E) binding to 
p66α, MBD2(REE), and MBD2(REER) binding to p66α(RRE) and MBD2(REE) binding 
to p66α(RRD). 
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Figure 1.7: Ionic interactions of the coiled-coil complex. To test whether geometric 
constraints prevent close interaction between charged residues in the charge swap mutant 
proteins, bidentate hydrogen bond restraints between p66α-MBD2 residues Arg-166-Asp-
217 and Glu-156-Arg-231 (and the respective charge swap mutations) were incorporated, 
and the side-chain conformations were minimized by simulated annealing molecular 
dynamic calculations. Representative minimized structures are shown for both the wild 
type and mutant complexes; the minimized charged side chains are depicted as sticks, and 
the bidentate hydrogen bonds are indicated by dashed lines. 
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1.4.6 The MBD2 and p66α coiled-coil domains have highly complementary 
electrostatic surface potentials  
To investigate differences between the wild type and charge swap complexes, the 
electrostatic potential of the individual peptides were calculated by the APBS (34) and mapped to 
the surface with the APBS plugin tool in PyMOL (35). This analysis reveals that the wild type 
peptides have complementary alternating positive (blue) and negative (red) surface potentials 
(Figure 1.8A). The MBD3, MBD3L1, and MBD3L2 homologues show a very similar pattern 
(Figure 1.8C). The a and a’ hydrophobic “knobs” are largely positioned where the surface 
potentials change from positive to negative (indicated by arrows in Figure 1.8A).  
The electrostatic surface potential of the charge swap mutations are highly complementary 
as well (Figure 1.8B), indicating that the chosen mutations did restore the specific charge 
interactions. However, the interaction surfaces on each of the mutant peptides are more 
uniformly positive (p66α) or negative (MBD2). Hence the hydrophobic knobs are now 
positioned within a more uniform electrostatic charge potential. 
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Figure 1.8: Electrostatic surface potentials of the coiled-coil complex. The electrostatic 
surface potentials for wild type (A) and mutant (B) p66α and MBD2 coiled-coil domains 
as well as for MBD3, MBD3L1, and MBD3L2 coiled-coil domains (C) were calculated 
with the APBS (34) tool in PyMOL (35) and the surface potential colored from red to blue 
(-1 to +1 eV). The intermolecular contact surface is shown for each with the binding 
partners depicted as a ribbon diagram for orientation. The location of hydrophobic 
residues at a and a’ positions are indicated with arrows (A) for the wild type peptides. 
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1.5 Discussion 
Here we have presented biophysical analyses of the heterodimeric anti-parallel coiled-coil 
complex between p66α and MBD2 homologues. This represents one of the few studies of a 
native anti-parallel coiled-coil complex and, to our knowledge, the only such study comparing a 
family of homologous coiled-coil domains. The p66α-MBD2 complex demonstrates several 
unusual features including the propensity of the individual domains to form monomeric helices 
in isolation, a clear lack of oligomerization for MBD2 even at fairly high concentrations (300 
µM), and a requirement for minimum helical content in isolation to bind with high affinity. 
Comparing the different homologous coiled-coil domains, we find that the MBD2 and 
MBD3 domains bind with an ~10-fold greater affinity than either the MBD3L1 or MBD3L2 
domains. This difference reflects a larger unfavorable change in entropy that is not fully 
compensated by a more favorable change in enthalpy when comparing MBD3L1 and MBD3L2 
with MBD2. These changes correlate with the observation that MBD3L1 contains less preformed 
helical content than MBD2 (7% versus 25%, respectively). Hence MBD3L1 binding to p66α 
involves a coil to helix transition that reduces internal degrees of freedom yielding a large 
unfavorable change in entropy while at the same time forming backbone hydrogen bonds of an 
α- helix providing a favorable enthalpy change. Furthermore, mutating a non-contact glutamate 
of MBD2 to a glycine (E225G) reduces helical content (from 25% to 9%) and greatly reduces the 
binding affinity, whereas the reverse mutation in MBD3L1 (G159E) increases helical content 
(from 7% to 16%) and increases binding affinity. Taken together, these experiments show that 
high affinity binding requires minimal preformed helical content of the individual coiled-coil 
domains. 
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This requirement for preformed helical content differs from other coiled-coil complexes 
that often show evidence of a coil to helix transition upon binding (40). For example, binding and 
folding of the GCN4 coiled-coil dimerization domain has been well characterized with 
conflicting results. In general, thermodynamic unfolding of GCN4 reflects a two-state transition 
such that binding appears coupled to folding (41). However, NMR (42) and mutation analyses 
(43) indicate that pre-existing helical content promotes complex formation. In contrast to earlier 
studies (44), the latter results suggest that the transition state involves interaction between 
preformed helical segments (45). 
In more recent studies of the oligomerization domain (SARAH) from serine/threonine 
mammalian sterile 20-like kinase (MST1), thermodynamic analyses show that this coiled-coil 
domain remains unstructured in isolation and folds upon binding (40). The unstructured state of 
the monomeric SARAH domain allows the protein to adopt different structures and bind 
different partners. In contrast to these prior studies, the coiled-coil domains of MBD2 and 
homologues do not form homodimeric complexes. The lack of homodimerization simplified 
analysis and allowed us to probe the relationship between helical content of the MBD2 monomer 
with heterodimer formation. 
Given the propensity to form helices in isolation and the large hydrophobic surface of the 
coiled-coil domains, one would anticipate that the individual peptides should homo-oligomerize 
in isolation, especially at high concentration. However AUC analyses show that the coiled-coil 
domains of MBD2 and each of the homologues do not homo-oligomerize. In fact, the MBD2 
remains entirely monomeric even at 300 µM concentration (Figure 1.3A). Therefore, the coiled-
coil domains do not form homo- or heterodimeric complexes between the different homologues 
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as has been suggested previously. Instead these domains remain isolated monomeric helices until 
binding p66α as a 1:1 complex. 
As we demonstrated previously (1), charged residues contributed to binding specificity such 
that reversing the charge of three residues in p66α eliminates binding to MBD2. Here we have 
shown that introducing complementary charge changes in MBD2 restores binding to the charge 
mutant of p66α but not with the same high affinity as the wild type complex. The inability to 
bind with high affinity does not reflect a lack of helical content nor does it reflect geometric 
restraints on the relative positioning of the charged residues. Therefore, we hypothesize that the 
electrostatic surface potential generated by these charged residues contributes to high affinity 
association. The wild type electrostatic surface potential alternates between positive and negative 
regions such that the branched hydrophobic residues (at position a) fall at the interface between 
these oppositely charged regions. In contrast, the surface potentials for the mutant proteins are 
more uniformly positive (p66α(ERR)) or negative (MBD2(REE)). Even though the charge swap 
mutations generate complementary electrostatic surface potentials, these surface potentials are 
qualitatively different from the wild type proteins. Based on these observations we suggest that 
optimal high affinity binding between MBD2 and p66α depends on the alternating surface 
potential. One possibility for this requirement is that the position of the hydrophobic residues 
between alternating surface potentials may stabilize induced dipole moments and increase van 
der Waals interactions between the two chains. 
These studies underscore how small changes in helical content and electrostatic interactions 
can modulate the binding affinity of the coiled-coil domains. In this case, the changes led to a 
10-fold binding affinity preference of p66α for MBD2 and MBD3 over the MBD3L1 and 
MBD3L2 homologues. MBD3L1 and MBD3L2 homologues are expressed in specific tissue 
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types (24), whereas MBD2 and MBD3 are more ubiquitous. Each of these proteins recruits the 
same NuRD chromatin remodeling complex; however, MBD3L1 and MBD3L2 lack a methyl-
cytosine binding domain (Figure 1.2A) and as such target the complex to distinct regions (24-26, 
46).In previous studies we showed that the coiled-coil interaction between p66α and MBD2 was 
critical for the formation of a functional NuRD complex. Enforced expression of the isolated 
p66α peptide blocked recruitment of the native p66α protein and the Mi2 chromatin remodeling 
protein (1). Consequently the p66α peptide blocked DNA methylation dependent gene silencing 
by the MBD2 protein. The relative binding hierarchy of the MBD3 homologues indicates that the 
ubiquitously expressed MBD2 and MBD3 should effectively compete with MBD3L1 and 
MBD3L2 for a functional NuRD in those cell types that co-express the homologous proteins. In 
this manner, fine-tuning of coiled-coil domain binding affinity can be used to establish 
hierarchical binding networks for tissue specific gene regulation and chromatin remodeling. 
In summary, we have shown that differences in helical content and charge distribution 
dictate high affinity anti-parallel heterodimeric coiled-coil complex formation between MBD2 
homologues and p66α. The MBD2 homologues remain monomeric helices in isolation, even at 
high concentrations, poised to bind p66α with high affinity and specificity. Although the coiled-
coil domain represents a relatively simple binding motif, subtle variations in sequence can 
modify binding affinity and specificity. Understanding the determinants of high affinity binding 
will inform the development of inhibitors of coiled-coil complexes for potential therapeutic 
benefit (19). 
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Chapter 2 
 
Dynamic behavior of 
MBD4 in methylated 
DNA recognition
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2.1 Abstract 
Having a C-terminal glycosylase domain in addition to N-terminal methyl-cytosine binding 
domain (MBD) makes methyl-cytosine binding domain 4 (MBD4) a unique member of family of 
MBD proteins which recognize methylated Cytosine-Guanine (mCpG) dinucleotide. MBD4 
serves as a potent DNA glycosylase in DNA mismatch repair and is also shown to be involved in 
transcriptional repression. The MBD domain of MBD4 can bind TpG dinucleotide in addition to 
mCpG and thus drives specificity for the glycosylase to act on, therefore understanding how 
MBD binds methylated DNA sequence is crucial. Here, we present a solution structure of the 
MBD of human MBD4 bound to DNA. Based on chemical shift changes and binding analyses, 
we show that the MBD of MBD4 can bind methylated as well as unmethylated, 
hydroxymethylated and mismatched (TpG) DNA with preference for mCpG. Further, with the 
help of chemical exchange studies we demonstrate the dynamics of methylated DNA recognition 
by MBD4. MBD4 exchanges slowly on two DNA binding sites on two separate pieces of DNA 
(inter-molecular) but if linked together on a single DNA (intra-molecular), MBD4 exhibits fast 
exchange between two sites. This suggests that MBD4 prefers to move along DNA using either 
sliding or hopping until it finds its target rather than searching through random three-dimensional 
diffusion. Introducing more bases or a defect between two sites on the same DNA molecule does 
not affect the fast exchange rate, indicating that MBD4 may use hopping mechanism for moving 
along the DNA. Furthermore, we demonstrate the effect of NaCl concentrations on inter and 
intra molecular exchange of MBD4. This is the first time we demonstrate a hopping mechanism 
of MBD4 in targeting a relatively diverse DNA methylation mark. 
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2.2 Introduction 
2.2.1 Methylated DNA binding proteins  
DNA methylation represents a key epigenetic signal involved in developmental and tissue 
type specific gene silencing, chromatin modifications, and aberrant silencing of tumor suppressor 
genes in cancer. Central to these regulatory functions is a family of proteins that selectively bind 
symmetrically methylated CG dinucleotide sequences (mCpG) through a common 
methylcytosine binding domain (MBD). The MBD was first described as a ~70 amino acid 
region in the MeCP2 protein (1)  and subsequently identified by homology in six additional 
proteins, MBD1-6 (2). Each MBD protein has a unique domain architecture and amino acid 
sequences outside of the MBD itself (with the exception of MBD2 and MBD3, Figure 2.1). 
MeCP2 (methyl CpG binding protein 2), is a 50 kDa protein encoded by four exons that 
lead to two different splice variants called MeCP2α and MeCP2β depending on inclusion of exon 
2. It has MBD in its N-terminal region and a transcriptional repressor domain (TRD) in its C-
terminal region. The TRD domain of MeCP2 causes repression in response to a methylated DNA 
sequence signal seen by the MBD domain. Sin3A, a complex containing histone deacetylase 
(HDAC1 and HDAC2), is recruited by the TRD domain. Mutations in the MBD or TRD lead to 
Rett syndrome, severe autism spectrum disorder (3). 
MBD1 is a 55 kDa protein which contains MBD at the N-terminal region, a TRD at the C-
terminal region and at least 2 (most likely 3) CXXC domains between MBD and TRD. 
Repression by MBD1 is mediated by K9 of Histone H3 methylation which recruits complexes 
like CAF-1, SETDB1. MBD1 knockout mice show affected abnormal differentiation and 
chromosome instability (4). 
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Figure 2.1: Comparison of MBD proteins: A) Domain organization of MBD proteins is 
proportionally depicted.  Note that all proteins have at least one domain in addition to the 
MBD. B) CLUSTAL format alignment of MBD domains is created using MAFFT 
(v7.029b). Key contact residues are shown in bold and predicted secondary structure 
motifs are shown above. 
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MBD2 and MBD3 are two MBD proteins which share homology outside their MBD 
domains. A shorter variant of MBD2, MBD2b (262 amino acids) and MBD3 share 71% 
sequence identity throughout (2). Both MBD2 and MBD3 have a MBD domain at its N-terminus 
and a coiled-coil domain at the C-terminus (Figure 2.1A). Both recruit a large nucleosome 
remodeling and deacetylation complex (NuRD) that contains a histone deacetylase (HDAC1 or 
HDAC2) and a nucleosome remodeling protein Mi2 (5). MBD2 selectively associates with 
mCpG while MBD3 does not, reflecting amino acid differences within DNA contacting regions 
of the MBD (6, 7). A single tyrosine (MBD2) to phenylalanine (MBD3) substitution alters 
interaction with the methyl group of methylcytosine and abolishes selectivity for methylated 
DNA. Importantly, based on mass spectrometry analyses of purified complexes, MBD2 and 
MBD3 are mutually exclusive components of the NuRD complex (8). Experimental knockout 
mouse of MBD3 is shown to embryonically lethal (9), but MBD2 knockout mice are viable and 
only show mild changes in behavior and reduced susceptibility to tumorigenesis (10). 
MBD4 (also known as methyl CpG binding endonuclease 1, MED1) is the most unique of 
the lot, as it is a part of DNA repair machinery and has a glycosylase domain at its C-terminus in 
addition to its N-terminus MBD domain. The glycosylase domain of MBD4 has DNA repair 
function and removes the thymine in a mCpG·TpG double-stranded mismatch (2, 11, 12). The 
mCpG·TpG mismatch arises from hydrolytic deamination of a methylcytosine to thymine, which 
is one of the more common sources of germline and somatic DNA point mutations. The MBD 
from MBD4 preferentially binds mCpG·TpG, but it also recognizes mCpG sequences (11). 
MBD4 knock-out mice show increased tumor susceptibility (13).  
A few proteins that lack a MBD domain are also shown to recognize methylated DNA. 
Kaiso is a member of the BTB/POZ zinc finger domain family of proteins that bind methylated 
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CpG dinucleotide. Repressive activity of Kaiso involves N-COR corepressor complex which 
includes HDAC3 (4). MBD proteins constitute a major group of proteins that recognize DNA 
methylation mark. Genome wide promoter occupancy studies show that MBD proteins can be 
found at distinct but overlapping subsets of genes silenced by DNA methylation in cancer (14). 
Furthermore, silencing of specific methylated genes has been attributed to individual MBD 
proteins (i.e. MBD2 silences BRCA1 and GSTP1) (15-22). In this study, the focus is on MBD4 
and investigating its methylated DNA recognition abilities.  
2.2.2 Comparison of MBD domains from MBD proteins 
Figure 2.1B shows a sequence alignment for MBD domains from human MeCP2, MBD1, 
MBD2a, MBD3 and MBD4. Note that all MBD domains are homologous and are about 70 
amino acids long. Due to high degree of homology and similar target recognition (mCpG 
dinucleotide), MBD domains are thought to have similar structure and mechanism of action. The 
crystal structure of the MBD domain from MeCP2 (23), the NMR structure of MBDs from 
MBD1 (24) and MBD2 (25) proteins bound to a methylated DNA are known. All three structures 
show similar folds and also demonstrate that the key DNA contacting residues are conserved and 
form a similar DNA recognition interface. Secondary structure elements are depicted at the top 
of the sequence alignment and all MBD domains may exhibit these folds when bound to the 
DNA. The MBD domain when bound to a DNA has two prominent β strands (β1 and β2) 
connected by a loop (L1), a small β strand (β3) and followed by a helix (α1). Two key interacting 
arginine residues and one tyrosine residue are conserved among all MBDs and are shown in bold 
(Figure 2.1B). 
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Figure 2.2: Solution structure of the methyl binding domain of chicken MBD2 bound to 
a methylated promoter target sequence. A mixed rendering diagram (A) of the solution 
structure is presented. The methyl binding domain is shown as a ribbon diagram in cyan, 
DNA is shown as a tube model. A more detailed view of three critical residues involved 
in the protein:DNA interface (B) is shown as stick diagram with protein residues colored 
cyan and DNA bases colored yellow (methylcytosine) and magenta (guanosine) with 
select residues labeled. Adapted from Scarsdale et al. (2011) (25). 
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Figure 2.2, adapted from Scarsdale et al. (25), demonstrates the structure of the MBD from 
chicken MBD2 bound to a ten base pair methylated sequence from the ρ-globin promoter. Figure 
2.2A demonstrates that MBD2 is a major groove binder whereas Figure 2.2B illustrates 
importance of key contacting arginine and tyrosine residues. Binding of MBD to a specific DNA 
involves complex network of electrostatic and hydrophobic interactions. Arginine residues form 
a hydrogen bond with guanine and the aliphatic portion of the side-chains pack against the 
adjacent methyl group of methyl cytosine. A cation-π interaction between the guanidinium group 
of Arginine and pyrimidine ring is also shown to stabilize the interaction (26, 27). A key tyrosine 
residue specifically interacts with the methyl groups of one methylcytosine. Despite these 
similarities, the MBD proteins target different non-overlapping subsets of genes. Here, we study 
how MBD4 differs in its mode of recognition of methylated DNA variants. 
2.2.3 MBD4: multifaceted MBD protein with unique glycosylase ac tivity 
MBD4 was first identified in a bioinformatics study by its N-terminal MBD, which shares 
sequence homology with other MBD proteins. MBD4 also has another highly conserved C-
terminal DNA binding glycosylase domain and a long spacer domain linking it with the N-
terminal MBD domain (2). The glycosylase domain of MBD4 removes thymine and uracil paired 
with guanine base by base excision repair (BER) pathway. The hydrolytic deamination of 5-
methylcytosine and cytosine to thymine and uracil respectively (Figure 2.3), is a spontaneous 
event that causes 2-300 lesions in a cell per day; If not corrected, it leads to C:G to T:A 
transitions in the following round of DNA replication (28). Glycosylase of MBD4 is also shown 
to remove halogenated pyrimidines like 5-chlorouracil and 5-bromouracil paired with G that 
result from peroxidase-mediated inflammatory processes (29). Rai et al have also shown that the 
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Figure 2.3: A schematic representation of deamination and oxidation products of 5-
methylcytosine. The methyl group attached to the 5’ position of cytosine is circled in 
green. Oxidation and deamination are shown in red and blue, respectively. TET mediated 
oxidation products, 5-Formylcytosine and 5-Carboxycytosine are not excised by MBD4 
but Thymine DNA glycosylase (TDG) has shown to have activity towards these 
substrates (31). Figure adapted from Otani et al (2013) (32). 
50 
 
MBD4 can cause active DNA demethylation and thereby compliment DNMTs in carefully 
regulating DNA methylation mark (30) 
Unlike other members of the family of MBD proteins, MBD4 is the only one that contains 
a DNA glycosylase catalytic domain and therefore was classically thought to be involved in 
DNA repair rather than transcriptional suppression, but in 2005, Kondo and colleagues 
demonstrated that MBD4 represses transcription of certain genes in human cells and this 
involved Sin3A and HDAC activity. Though MBD4 has been demonstrated to be localized to 
hypermethylated promoters of affected genes, knockdown of MBD4 did not change the 
repression status of either of these promoters. This suggests that other MBD proteins may 
substitute for repression activity caused by MBD4 (33). It is also noteworthy that the MBD 
domain is a major grove binder whereas the glycosylase domain is a minor groove binder, and 
they both are separated by long spacer region (~280 amino acids) allowing them to work 
independently or complement each other. 
In the studies presented here, the focus is on the MBD domain of MBD4 and how it 
compares to other MBD domains studied to date in terms of structure and function. We have 
solved a solution structure of MBD domain of MDB4 and shown that it has similar structural 
folds (two β strands connected by a loop, a small β strand and a helix) exhibited by other MBD 
domains. Though similar, it exhibits certain features (a longer and more stable alpha helix, for 
example) which make it more closely related to MeCP2 than MBD1 and MBD2. Being 
considered as a mismatch repair enzyme, MBD4 is expected to bind not only methylated CpG 
but also TpG mismatched sites. Based on chemical shift changes and binding analyses, we show 
that MBD of MBD4 can bind methylated as well as unmethylated, hydroxymethylated and 
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mismatched (TpG) DNA with little preference for mCpG, thereby defining target specificity for 
MBD4.  
It has always been intriguing how DNA binding proteins accomplish the remarkable feat of 
finding their correct target sequences within huge genomic DNA. It has been proposed that, in 
order to reach their target site, proteins first translocate along nonspecific DNA, i.e. move along 
DNA that does not contain a cognate binding site (34). The mechanism underlying this so-called 
‘facilitated diffusion’, however, is still under debate. Here, using ‘MBD4 recognizing methylated 
DNA mark’ as a model we provide new insights on DNA-protein recognition. With the help of 
chemical exchange studies we demonstrate the dynamics of methylated DNA recognition by 
MBD4. MBD4 exchanges slowly on two DNA binding sites on two separate molecules of DNA 
(inter-molecular) but if linked together on a single DNA (intra-molecular), MBD4 exhibits fast 
exchange between the two sites. This suggests that MBD4 prefers to slide or hop across DNA 
until it finds its target rather than search through three-dimensional diffusion. Introducing more 
bases or a defect between the two sites on the same DNA does not affect the fast exchange rate 
indicating that MBD4 may prefer hopping over sliding as a mode of facilitated diffusion. 
Furthermore, we demonstrate that NaCl qualitatively affects inter and intra molecular exchange 
of MBD4. This is the first time we demonstrate the hopping mechanism of MBD4 in targeting a 
relatively diverse DNA methylation mark. 
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2.3 Materials and methods 
2.3.1 Protein expression and purification  
The methyl DNA binding domain of human MBD4 (amino acids 80-148) was cloned and 
expressed with a hexahistidine tag and as a thioredoxin fusion proteins in a modified pET32a 
vector (35). The expression vector was transformed into the BL21(DE3) E. coli strain, grown at 
37 
0
C and induced with 1 mM isopropyl-β-d-thiogalactopyranoside at an A600 ~ 0.8. Induced 
bacteria were harvested and lysed with the B-PER reagent (Thermo Scientific). The soluble 
fraction was passed over a nickel-sepharose column and protein was eluted with a step gradient 
of imidazole. After removing the thioredoxin and hexahistidine using thrombin cleavage, the 
protein was further purified by gel filtration over a Superdex-75 column (GE Healthcare).  For 
additional purity, protein was cleaned using reverse phase column SOURCE-15RPC (GE 
Healthcare) and eluent was dialyzed against physiological buffer. The thioredoxin fusion protein 
was used for surface plasmon resonance (SPR) studies. The fusion protein was expressed in a 
similar manner and after purification over a nickel-sepharose column, it was passed over MonoS 
10/100 GL (GE Healthcare). Size exclusion chromatography was used for additional 
purification. Resulting thioredoxin fused MBD was > 95% pure as estimated by SDS-PAGE 
analysis. Uniform double (
13
C, 
15
N) and triple (
13
C, 
15
N, 
2
H) labeled protein samples were 
generated by standard techniques. The final concentrations of all protein samples were 
determined by monitoring UV absorbance at 280 nm. 
2.3.2 DNA purification 
Complimentary DNA oligonucleotides were purchased from Integrated DNA technologies. 
Forward and reverse oligonucleotides were dissolved in standard buffer (20 mM Tris pH 8.0) 
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and mixed in equimolar concentrations. After heating at > 363K for 10 minutes, mixture was 
cooled slowly to room temperature (annealed) allowing formation of double stranded (DS) DNA. 
Subsequently, DS DNA was purified by ion exchange chromatography on MonoQ 10/100 
column (GE Healthcare).  3’ biotinylated forward oligonucleotides (purchased from Integrated 
DNA technologies) were mixed with regular unlabeled complimentary reverse oligonucleotides, 
annealed and further purified using ion exchange for binding studies using surface plasmon 
resonance. The final concentration of DS DNA was determined by monitoring UV absorbance at 
260 mm. 
2.3.3 Surface plasmon resonance 
Protein and DNA samples were prepared in standard buffer (10 mM HEPES pH 6.5, 50 
mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 1 mM DTT).  Binding affinities of MBD domain with 
3’ biotinylated DNA variants were studied using a Sensor SA chip on Biacore T200 (GE 
Healthcare).  Biotinylated DS DNAs were immobilized to the experimental channels of SA chip 
using biotin-streptavidin chemistry until the final response units were in the range of ~ 50-100, 
control channels were blocked without linking DNA. Various concentrations of thioredoxin 
fused MBD4 was passed over control and experimental channels (at a flow rate of 30 µl/min) in 
running buffer (10 mM HEPES pH 6.5, 50 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 1 mM 
DTT, 0.05% polysorbate 20).  At least one concentration of MBD4 was repeated in triplicate to 
estimate error and thereby determine quality of data. The sensogram which resulted from 
subtracting the control channel response from the experimental channel response was fit by a 
steady state analysis using manufacturer’s software.  
2.3.4 NMR experiments  
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Purified 
15
N-MBD4 protein was mixed with purified DS DNA oligonucleotides, buffer-
exchanged into 10 mM NaPO4, pH 6.5, 1 mM dithiothreitol, 10% D2O and 0.02% sodium azide. 
Standard NMR experiments for resonance assignments, distance and torsional angle restraints 
were collected on a Bruker Avance III
TM 
700MHz NMR spectrometers at 25
0
C. Analysis and 
structure calculation (described in Chapter 3) resulted in a three dimensional solution structure of 
MBD4 on a methylated DNA.  
To compare binding preference with HSQC experiments, 
15
N-MBD4 and respective DNA 
were mixed at 1:1.1 ratio (10% excess DNA), buffer exchanged into standard buffer (mentioned 
above) and concentrated to 200 µM.
 15
N-HSQC spectra (amide and Arg Nε region) for MBD4 
when bound to 17 bp methylated (1xmCpG) DNA, unmethylated, hydroxymethylated and 
mismatch DNA (Table 2.1) were collected. For chemical exchange studies MBD4 was mixed 
with excess DNA in a ratio corresponding to four methylated DNA binding sites for each MBD4. 
HSQC and TROSY HSQC experiments were collected for studying dynamics. The effect of 
increasing NaCl were measured by titrating a 300 mM stock of NaCl in standard buffer into 
previously used sample to give final salt concentration ranging from 20-100 mM. 
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2.4 Results 
2.4.1 Solution structure of methyl binding domain of MBD4 on methylated DNA  
We present a solution structure of the methyl binding domain from human MBD4 (amino 
acids 80–148) bound to a 10bp DNA fragment containing a methylated CpG using 
multidimensional NMR spectroscopy. The 10 bp DNA used for this studies is the same sequence 
used by Scarsdale et al (25) and is a known target for MBD proteins and has one centrally located 
mCpG dinucleotide (Table 2.1). The reported solution structure is in the final stages of 
refinement based on ~800 NOE restraints and were calculated by simulated annealing using the 
Xplor-NIH software package (36). In Figure 2.4 a best-fit superimposition cartoon diagram of 
MBD4 methyl binding domain when bound to a methylated DNA is shown for an ensemble of 
10 calculated lowest energy structures. Chapter three describes the process of solving the three 
dimensional protein structure using NMR spectroscopic techniques.  
The crystal structure of MBD domain from MeCP2 (23), the NMR structure of MBDs from 
MBD1 (24) and MBD2 (25) proteins bound to a methylated DNA are known. All three structures 
show similar folds and also demonstrate that the key DNA contacting residues are conserved and 
form a similar DNA recognition interface (Figure 2.1). Like these domains, MBD4 has two 
prominent β strands (β1 {Residue E91-Q96} and β2 {R105-I111}) connected by a loop (L1 
{R97-G104}), a small β strand (β3 {L116-K117}) followed by an α helix (α1 {K121-L128}). 
The MBD domain of MBD4 is most similar to that of MeCP2 and proposed to be evolved 
closely with MeCP2 (2, 37). Similar to MeCP2, the helix α1 is longer and well defined in MBD4 
than in MBD2 and MBD1. Recently, Otani et al, have released a crystal structure of mouse 
MBD4 methyl binding domain bound to methylated DNA and our findings are congruent with 
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their structure (32). The MBD domain of MBD4 is also relatively well folded in isolation (not 
bound to DNA). It undergoes further structural changes upon binding to DNA but these changes 
are not as dramatic as seen in case of MBD2. MBD2 is proposed to fold upon binding to DNA 
whereas MBD4 is inherently structured even in the absence of DNA.  
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Table 2.1: Table of all DNA constructs used. Complimentary strands were annealed as described 
in 2.3.2. Central CpG dinucleotide and its modifications are highlighted in bold (m = methylated, 
hm = hydroxymethylated). 5’- 3’ (forward) oligonucleotides were biotinylated at 3’ end for 
surface plasmon resonance experiment (not shown in the table). 
Oligonucleotide 
name 
Sequence 
17bp 1xmCpG 
5’-GAGGCGC TmCGG CGGCAG-3’ 
3’-CTCCGCG  AGmCC GCCGTC-5’ 
17bp unmethylated 
5’-GAGGCGC TCGG CGGCAG-3’ 
3’-CTCCGCG  AGCC GCCGTC-5’ 
17bp 
hydroxymethylated 
5’-GAGGCGC ThmCGG CGGCAG-3’ 
3’-CTCCGCG  AGhmCC GCCGTC-5’ 
17bp mismatch 
5’-GAGGCGC TmCGG CGGCAG-3’ 
3’-CTCCGCG  AGTC GCCGTC-5’ 
10bp 1xmCpG 
5’-GGA TmCGG CTC-3’ 
3’-CCT AGmCC GAG-5’ 
10bp Inverted 
5’-GGA CmCGA CTC-3’ 
3’-CCT GGmCT GAG-5’ 
Tandem short 
(20bp) 
5’-GGA TmCGG CTC GGA CmCGA CTC-3’ 
3’-CCT AGmCC GAG CCT GGmCT GAG-5’ 
Tandem long 
(30bp) 
5’-CACGGA TmCGG CT CCCC CGAG TmCGG TCCCGC-3’ 
3’-GTGCCT AGmCC GA GGGG GCTC AGmCC AGGGCG-5’ 
Tandem long 
nicked (30bp) 
5’-CACGGA TmCGG CT CCCC CGAG TmCGG TCCCGC-3’ 
3’-GTGCCT AGmCC  GA GG - - GCTC AGmCC AGGGCG-5’ 
58 
 
 
Figure 2.4: Solution structure of MBD4 methyl binding domain bound to a methylated 
DNA. A best-fit superimposition cartoon diagram of MBD4 methyl binding domain 
(blue) when bound to a methylated DNA (not shown) is shown for the ensemble of 10 
calculated lowest energy structures. Like other MBD domains, it has two prominent β 
strands (β1 and β2) connected by a loop (L1), a small β strand (β3) and an α helix (α1) 
that follows. Figure was generated using PyMOL (38) In the inset, a recent crystal 
structure of mouse MBD4 methyl binding domain with a methylated DNA (32) is 
depicted which shares similar binding domain as the human variant. 
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2.4.2 MBD4 prefers mismatch and methylated DNA over unmethylated and 
hydroxymethylated DNA 
Proposed to being involved in rather diverse biological roles, including repression, base 
excision repair et cetera, the most preferred target sequence for the MBD domain of MBD4 was 
not clear. In this study, we analyzed MBD4 preference for methylated, unmethylated, mismatch 
and hydroxymethylated double stranded DNA oligonucleotides. A 17 base pair oligonucleotide 
with centrally methylated CpG was used for methylated DNA and the central bases were 
changed for other DNA variants (Table 2.1). Binding constant analysis was carried out with 
surface plasmon resonance and results are summarized in Table 2.2. MBD4 binds methylated 
DNA sequence with a fast on-rate and off- rate with a KD ~725 nM (Figure 2.5). Affinity for 
mismatched (TpG) DNA was ~15 fold less than methylated DNA but it bound ~3 fold and ~7 
fold tighter than unmethylated and hydroxymethylated DNA. This shows that MBD4 has 
relatively higher preference for methylated and mismatch DNA over unmethylated and 
hydroxymethylated DNA. MBD4 showed a similar binding affinity towards tandem DNA (20 bp 
long oligonucleotide with two methylated CpG sites) to that of methylated DNA with one 
binding site. Stoichiometry for this interaction was calculated to be 1.0 indicating that MBD4 
occupies just one of the two binding sites. This observation indicates that having two closely 
spaced binding sites does not work synergistically to improve MBD4 binding. Although, MBD4 
has higher affinity for methylated DNA, binding is weaker compared to other MBD domains, 
e.g., MBD2 exhibits stronger binding (KD ~ 50 nM) towards the same 17 bp DNA with one 
methylated CpG site (25). Therefore, although MBD4 may not be the best MBD protein for 
targeting CpG it can easily target mismatch DNA, towards which other MBD proteins have 
weaker affinity.  
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Figure 2.5: Binding affinity of MBD4 to methylated and other DNAs. (A) Sensogram of 
surface plasmon resonance analysis for varying concentrations of MBD4 binding to a 3’-
biotinylated DS DNA coupled to a Sensor Chip SA measured on a Biacore T200 (GE 
Healthcare). (B) Steady state binding response for MBD4 binding to methylated, 
unmethylated, hydroxymethylated, tandem, and TpG DNA. The data were fit using the 
Biacore T200 evaluation software. For comparison, the response units for each were 
normalized to an Rmax = 100 (Table 2.2). 
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Table 2.2: Binding analyses of MBD4 to methylated DNA. Surface plasmon resonance studies 
were performed and the dissociation constants (KD) between MBD4 methylated DNAs were 
calculated.  
Methylated DNA in 
complex with MBD4 
KD Rmax Chi square 
17bp 1xmCpG 725±3.4 nM 278.8 0.0189 
17bp mismatch 11.2±1.3 µM 764.5 5.75 
17bp unmethylated 34.47±2.6 µM 941.7 72.4 
17bp hydroxymethylated 80.6±14 µM 856 31.6 
Tandem short (20bp) 881±23 nM 85.54 0.0396 
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Further, with the help of 2D HSQC analysis of MBD4 bound to various DNA 
oligonucleotides, we demonstrated that MBD4 prefered methylated and mismatch DNA over 
unmethylated and hydroxymethylated DNA. 2D HSQC spectra of 
15
N-MBD4 showed 
characteristic chemical shifts for certain reporter residues when bound to methylated DNA. 
Figure 2.6A shows an HSQC for MBD4 when bound to methylated DNA and reporter residues 
(R97Hε and G100HN) are circled. Subsequent HSQC spectra of MBD4 with unmethylated, 
hydroxymethylated and mismatch DNA were also collected and changes in chemical shifts of 
R97Hε and G100HN were observed. Hε of R97 shifts downfield upon binding to methylated 
DNA (shown in red Figure 2.6B), but its chemical shifts are different when bound to 
hydroxymethylated and unmethylated DNA. Also, peak for R97Hε is not seen when on 
mismatch DNA indicating that it is binding to mismatch DNA in relatively different manner and 
thereby giving a broad peak which is not visible. G100HN, on the other hand, clearly shows that 
chemical shifts are similar when bound to methylated and mismatch DNA. Unmethylated and 
hydroxymethylated DNA do not change chemical shifts for G100HN (Figure 2.6C). This clearly 
demonstrates that MBD4 has higher binding preference for methylated and mismatch (TpG) 
DNA. Considering the role of glycosylase domain of MBD4 in excising TpG mismatch bases, 
affinity towards TpG dinucleotide may help with targeting the glycosylase domain to mismatch 
sites. 
63 
 
 
 
Figure 2.6: NMR spectra of 
15
N-MBD4. 2D 
15
N-HSQC spectra (amide and Arg Nε 
region) for MBD4 when bound to methylated (1xmCpG) DNA is shown in panel A. 
Reporter residues that have characteristic chemical shift changes when bound to various 
DNAs are marked with a circle. R97Hε and G100HN are two reporter residues whose 
distinct chemical shifts are shown in panel B and C. 
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2.4.3 MBD4 exchanges slowly between two separate DNA binding (inter -
molecular) sites on two DNA molecules 
Methylated CpG dinucleotide is symmetrical and protein recognizing it can bind in two 
orientations. However, it was shown in the past that MBD2 predominantly prefers one 
orientation over the other depending on residues just outside the mCpG pair and inverting those 
residues can change the orientation preference (25). This subtle change in binding is reflected in a 
characteristic change in chemical shifts of certain reporter residues and thus serves as a readout 
for the orientation in which the MBD domain is bound, which in turn indicates the specific 
sequence to which MBD4 is bound. In a mixed population of two such DNA molecules, the final 
chemical shift observed for the reporter residue depends on the relative distribution of the 
population of MBD protein, and how fast it is exchanging between the two states. Here, we use 
this phenomenon, to explore how the MBD of MBD4 exchanges between two mCpG on 
different DNA oligonucleotides. 
10 base pair double stranded DNA oligonucleotide with central four bases in regular and 
inverted position (Table 2.1) were used for the study. MBD4 shows a single orientation 
preference on a given DNA and thus have specific chemical shifts for reporter residues when 
bound to a regular versus inverted DNA sequence. When we bound 
15
N-MBD4 methyl binding 
domain to a mixture of the regular and inverted sequences (1:2:2 molar ratio of MBD4, regular 
and inverted DNA), two separate peaks were observed for reporter residues (Figure 2.8). These 
two peaks corresponding to two binding states, indicated that MBD4 exchanges slowly 
(millisecond or longer time regime) on intermolecular DNA binding sites. Further with the help 
of the HSQC  based zz-exchange spectroscopy, we  determined the  exchange  rate for  this slow  
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Figure 2.7: The zz-exchange experiment for the inter-molecular exchange of MBD4 
between mCpG sites. (A) 
15
N-MBD4 was bound to a 1:1 mixture of methylated 10bp 
1xmCpG and 10bp inverted DS DNA, which show distinct chemical shifts for select 
amide resonances (R105, F106) are shown for varying z-exchange delays (2.5ms and 
25ms). Autopeaks A (regular) and B (inverted) and crosspeaks AB and BA are identified 
and represent slow chemical exchange between the two binding sites during the z-
exchange delay. (B) The intensities for auto and exchange peaks of F106 as a function of 
mixing time are shown. 
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inter-molecular exchange. 2D 
15
N-HSQC z-exchange spectra with varying time delays reveal a 
buildup of exchange peaks consistent with the exchange rates in the ~20 ms time regime (Figure 
2.7). 
In Figure 2.7A chemical shifts for two reporter residues R106HN and F106HN are shown. 
In z-exchange experiments (39), delays are added to allow transfer of magnetization between two 
states, A (when bound to regular) and B (when bound to inverted DNA). In this mixing period 
‘T’, due to dynamic exchange between two states, nuclei experience different magnetic 
environment and give rise to exchange cross-peaks. The magnetization is transferred back to the 
proton for detection. As a result of this experiment, four peaks (two autopeaks A and B 
corresponding to regular and inverted binding mode and two crosspeaks AB and BA) emerge 
and are shown in Figure 2.7A. Delays of 0.1, 2.5, 5, 10, 17.5, 25, 37.5, 50, 100, 200 ms were 
used and buildup of crosspeaks was observed. Intensities of the four peaks after each mixing 
time were recorded and plotted as a function of time (Figure 2.7B) and used for calculating 
exchange rate which was found to be ~20 ms. We measured the exchange rate at 200 µM and 
333 µM concentrations of MBD4 and found no difference in exchange rates.  
2.4.4 MBD4 exhibits fast exchange between two binding sites (intra -molecular) 
linked on the same DNA oligonucleotide 
To test whether MBD4 exchanges more rapidly between two binding sites in the same 
DNA molecule, we bound MBD4 to a 20 base pair oligonucleotide resulted from tandem 
covalent linking of 10 bp regular and 10 bp inverted DNA used in the earlier experiment 
(Table2.1). 2D 
15
N-HSQC no longer showed distinct peaks for two bound states, instead a single 
peak was observed for each  amide backbone  consistent with fast exchange between sites ( ~µs  
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Figure 2.8: Inter-molecular and intra-molecular exchange of MBD4 between mCpG 
sites. (A) Schematic representation demonstrating that the MBD4 when mixed with a 1:1 
mixture of methylated 10bp 1xmCpG and 10bp inverted DS DNA showed slow exchange 
(shown in red), whereas exhibit fast exchange when bound to a tandem 30bp DNA 
(shown in blue). (B) TROSY HSQC spectra showing distinct chemical shifts for select 
amide resonances (R105, F106) when bound to 1:1 mixture of methylated 10bp 1xmCpG 
and 10bp inverted DS DNA (red), tandem 30bp (blue) and tandem nicked 30bp (green). 
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time regime). This data suggested that MBD4 showed facilitated diffusion and changed 
orientation after finding inverted methylated CpG. In this construct MBD4 was changing 
orientation with respect to the 10bp DNA and still showing a fast exchange rate. Another 30 base 
pair tandem DNA was designed where in entire 10bp inverted DNA was flipped so that the 
direction of MBD4 need not change while moving along the DNA, even though orientation with 
respect to bases outside mCpG can change. A few bases were added to avoid self-annealing; this 
construct (Tandem long 30bp) is listed in Table 2.1. As the longer DNA was mixed with MBD4, 
the overall complex was getting larger and therefore, modified TROSY based HSQC 
experiments were used for these studies. Peaks observed in TROSY experiments are shifted 
diagonally compared to corresponding peaks from HSQC.  
We observed two reporter residues, R105 and F106, after mixing 
15
N-MBD4 (200 µM) 
with 30 bp Tandem DNA (400 µM) and resultant peaks in blue can be seen in Figure 2.8B. For 
both residues, two peaks corresponding to the slow exchange are not observed, indicating that it 
does not exhibit slow exchange but instead only a single peak for R105 is observed intermediate 
between the two indicating that MBD4 exhibits fast exchange between the linked sites. Due to 
lack of an exchange peak for F106, it can be deduced that MBD4 exchanges in an intermediate 
regime. In conclusion, MBD4 exchanges faster between two DNA binding sites if sites are 
covalently linked. MBD4 can easily find its next target if it is intra-molecular versus inter-
molecular. This data suggest that MBD4 uses facilitated diffusion mechanism along the DNA to 
help find its binding site. 
2.4.5 Addition of small defects in double stranded DNA does not affect facil itated 
diffusion exhibited by MBD4  
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Based on earlier experiment, MBD4 can find the next binding site quicker if it is linked 
covalently, indicating that MBD4 either slides or hops along the DNA sequence rather than using 
random 3D-diffusion. Once in proximity of DS DNA, MBD4 does not come off and keeps 
moving along the stretch of non-specific DNA binding sites until it finds a high affinity binding 
site (mCpG in this case). To test whether a defect in the DNA can impact MBD4 movement 
along the DNA sequence, we introduced a small defect in a double stranded DNA and observed 
the two reporter residues, R105 and F106. We used a nicked version of 30bp tandem DNA used 
earlier. It has two base pairs missing on one of the strands and the construct is listed in Table 2.1. 
Figure 2.8B shows result of this experiment (green) and it is very similar to 30 bp Tandem DNA. 
Adding a small defect in double stranded DNA (missing nucleotides in this case) does not cause 
MBD4 to fall off the DNA, and the overall exchange rate is similar to that of MBD4 on Tandem 
30bp DNA. This data suggest that MBD4 does not always slide along the double stranded DNA 
and it may translocate with the help of small jumps along the DNA (hopping mechanism). 
2.4.6 Effect of Salt concentration on MBD4 exchanging on inter-molecular and 
intra-molecular DNA binding sites  
In an earlier work, it has been shown that salt concentration used in experimental 
procedures has dramatic effect on exchange rates of protein HoxD9 when bound to a DNA (40). 
Here, we study an effect of increasing concentrations of NaCl on exchange rates of MBD4 when 
on a i) 1:1 mixture of 10bp regular mCpG and 10bp inverted DNA, ii) tandem 30 bp, and iii) 
tandem 30 bp nicked DNA. Figure 2.9 summarizes results for reporter residues R105, F106. As 
shown earlier, R105 (top panel Figure 2.9) shows slow exchange for inter-molecular sites and 
exchanges rapidly on intra-molecular sites in standard buffer (0 mM NaCl added). As increasing 
concentrations of NaCl are added, intra-molecular peaks become sharper (blue and green) 
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indicating a qualitative change in exchange rate. With increasing concentrations of NaCl, inter-
molecular peaks (red) undergo profound changes, two peaks (indicating slow exchange) collapse 
into one peak (indicating fast exchange) at an average chemical shift. The other reporter residue 
F106 (bottom panel Figure 2.9) shows slow exchange for inter-molecular sites and intermediate 
exchange on intra-molecular sites in standard buffer (0 mM NaCl added). As increasing 
concentrations of NaCl are added, the two inter-molecular peaks (red) indicating slow exchange 
collapse into one peak at an average chemical shift indicating fast exchange. Peaks for inter-
molecular exchange were not visible and thought to have broadened because of intermediate 
exchange. With addition of NaCl, F106 goes from intermediate exchange to fast exchange; peaks 
appear at an average position (green and blue). Also, note that there is no noticeable difference 
between tandem DNA with and without a defect (blue versus green). Higher salt concentration 
pushes MBD4 to undergo rapid exchange between the two sites. 
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Figure 2.9: Effect of NaCl on inter-molecular and intra-molecular exchange of MBD4 
between mCpG sites. Distinct chemical shifts for select amide resonances, R105 (top 
panel), F106 (bottom panel) are shown when bound to 1:1 mixture of methylated 10bp 
1xmCpG and 10bp inverted DS DNA (red), tandem 30bp (blue) and tandem nicked 30bp 
(green). TROSY-HSQC experiments were carried out in standard buffer described in 
section 2.3.4. Increasing concentrations of NaCl (0 – 100 mM shown at the top panel) 
were added to the sample and spectra were recorded. 
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2.5 Discussion 
Multifaceted MBD4 is proposed to have diverse biological roles and a broad spectrum of 
binding targets. In the studies presented here, we demonstrate that MBD domain of MBD4 has 
ability to bind multiple substrates. Unlike other MBD proteins, e.g. MBD2, MBD4 not only can 
bind mCpG but it also can target mismatch, hydroxymethylated and unmethylated DNA marks. 
Although, overall structural motifs and binding recognition mode of MBD4 are very similar to 
known MBDs to date, there can be local structural differences that account for diverse DNA 
binding abilities of MBD4. The recently solved crystal structure of the mouse MBD domain of 
MBD4 shows that the DNA interface of MBD4 has flexible structural features and can 
accommodate various bases due to the extensive water network involved (32).  Our structure of 
human MBD4 is in the final stages of refinement and has a highly similar DNA interface to that 
of highly homologues mouse MBD4. We also show that MBD4 can bind methylated, mismatch, 
hydroxymethylated and unmethylated DNA with little preference for methylated and mismatch 
DNA. The 17 bp oligonucleotide with one methylated CpG used in this experiment showed a 
stronger binding (~50 nM) with MBD domain of MBD2. This suggests that MBD4 may not be 
the most preferred biological reader for methylated CpG mark. In contrast, the relatively strong 
affinity towards mismatch DNA suggests that MBD4 is likely to be the most preferred reader for 
TpG sites. Considering the role of the glycosylase domain of MBD4 in excising TpG mismatch 
bases, a higher affinity towards TpG dinucleotide seems logical and may help with targeting the 
glycosylase domain to mismatch sites. 
The MBD and glycosylase domains of MBD4 are linked with ~280 amino acid long largely 
disordered region of unknown function (12, 41). The MBD and glycosylase domains are self-
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sufficient for their action but are always linked with this linker domain. Previous work has 
shown that the glycosylase domain has no effect on its glycosylase activity towards a mismatch 
TpG whether it is acting alone or in context of full length MBD4 (12). Thymine DNA 
glycosylase (TDG) is another glycosylase which was thought to have very similar biological role 
as that of glycosylase of MBD4 but it does not have methyl DNA binding domain. TDG can bind 
methylated and mismatch DNA with greater affinity than the glycosylase of MBD4. 5-
formylcytosine and 5-carboxylcytosine, intermediates involved in the TET (ten-eleven-
translocation) dependent deamination pathway are also primary targets for TDG. On the other 
hand, Manvilla et al, have shown that the structure of glycosylase itself has little selectivity for 
acting on TpG dinucleotide over methylated or hydroxymethylated DNAs (31). Therefore, we 
hypothesize, having a MBD domain attached to glycosylase of MBD4 makes it better equipped 
to read TpG mismatches over TDG. Thus MBD4’s better binding preference for TpG sites 
provides specificity for the glycosylase to act on. This finding is important and provides a 
functional difference between action of TDG and MBD4. Also, MBD4 glycosylase is targeted to 
TpG mismatch sites within CpG islands but glycosylase itself cannot discriminate whether 
adjacent CpG sites are methylated or not (31). Therefore, MBD domain having higher affinity for 
methylated CpG over unmethylated CpG is crucial. The MBD domain can rapidly locate itself 
on mCpG islands and can very easily recognize TpG mismatch sites within the island. This 
suggests that the MBD domain can effectively recruit the glycosylase domain of MBD4 to its 
target (TpG) and thus underling its importance with respect to glycosylase activity of MBD4. 
 The role of MBD4 in repression is questionable. Kondo and colleagues proposed a role of 
MBD4 in transcription repression. Though MBD4 has been demonstrated to be localized to 
hyper-methylated promoters of affected genes, knockdown of MBD4 did not change the 
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repression status of these promoters. Since the MBD4 has a weaker binding affinity for mCpG 
when compared other MBD proteins, it is likely that repression was not a direct effect of MBD4 
or other MBD proteins can easily substitute for the repression activity caused by MBD4. MBD4 
has also shown to accumulate on hydroxymethylated CpG sites and was thereby proposed to be 
active in DNA demethylation (41). From this study, the MBD domain of MBD4 can recognize 
hydroxymethylated DNA and, therefore, under certain circumstances (depending on stimulus and 
property of linker region of MBD4) it can localize on hydroxymethylated site, recruit 
glycosylase and thereby can cause erasure of DNA methylation mark.  
It has always been intriguing how DNA binding proteins translocate into nuclei and 
accomplish the remarkable feat of finding their correct target sequences within huge genomic 
DNA. There are many examples in the literature about non-specific contacts made by DNA 
binding proteins with non-cognate DNA through phosphate backbone and base stacking (42, 43). 
It has long been proposed that, in order to reach their target site, proteins first translocate along 
nonspecific DNA, i.e. move along DNA that does not contain a cognate binding site (34) and 
then find its cognate DNA targets (facilitated diffusion). Time spent by a DNA binding protein 
on a non-cognate DNA helps protein with facilitated diffusion but it can also slow down the 
target search process if a protein spends too much time on non-cognate sites. A correct balance 
of facilitated diffusion and random 3D jumps seems to be the answer for ‘speed versus 
specificity’ exhibited by DNA binding proteins. Here, using the recognition of mCpG sites by 
MBD as a model we provide new insights into DNA-protein recognition.  
With the help of chemical exchange studies we demonstrate that MBD4 exchanges slowly 
on two DNA binding sites on two separate pieces of DNA (inter-molecular), but if linked 
together on a single DNA (intra-molecular), MBD4 exhibits fast exchange between the two sites. 
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This suggests that MBD4 prefers to hop across the DNA sequence until it finds its target rather 
than searching freely using three-dimensional diffusion. When sliding, DNA binding proteins 
once associated with non-specific DNA, do not dissociate and keep moving along the DNA in 
one dimension (reduced search space) to find its target site. When a defect (missing bases on one 
strand) was introduced on a nonspecific DNA sequence linking two cognate sites, the defect did 
not affect the fast exchange rate of MBD4. Not having two bases in a nicked version of Tandem 
30 bp DNA ensures that MBD4 is not always in direct contact with non-specific DNA. Though 
not in contact with DNA it manages to scan along the DNA and therefore still exchanges rapidly 
between two sites. Over a short distance, protein stays in close proximity (within the 
‘electrostatic field’ of DNA) without making direct contacts with it. These small ‘hops’ can be 
distinguished from 3D jumps where protein dissociates from the DNA completely and 
translocates to another DNA molecule in 3D space. Restriction enzyme EcoRV has shown to 
alternate between sliding and jumping on a non-cognate DNA sequence (34). Here, we 
demonstrate that while scanning for its cognate binding site, MBD4 moves along the non-
specific sites with the help of small ‘hops’. This is a crucial phenomenon, because in the nucleus, 
DNA is always associated with small proteins, e.g. cofactors, and these small obstacles can be 
overcome by the proposed hopping mechanism. 
DNA-protein interactions are highly dependent on ionic conditions, especially 
concentrations of monovalent ions. An increased NaCl concentration, for example, is shown to 
speed up association and dissociation between DNA and proteins (34, 40). Here, we demonstrate 
that increasing the salt concentration forces MBD4 to exhibit faster exchange rates; both inter-
molecular and intra-molecular. Salts have great effect on dielectric constants of the buffer and 
thereby greatly reduce association and dissociation times. This also weakens the electrostatic 
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field of the DNA and makes hopping less prevalent. The protein undergoes direct intermolecular 
transfer with the help of 3D jumps. In the experimental setup here, we have excess DNA binding 
sites and therefore it is very easy for MBD4 to find its cognate binding site. Inside the cell, 
however, if we allow protein to translocate only with the aid of 3D diffusion and calculate the 
chances of it colliding with its cognate binding site, proteins are thought to need hours before 
they can find their cognate sites. This is contrary to a millisecond timescale required for most 
DNA binding proteins to locate and activate their specific response genes in vivo (44). It was 
shown that the lac repressor finds its target site 1000 times faster than time predicted based on 
simple 3D diffusion and collision processes (45), suggesting facilitated diffusion mechanism.  
In summary, we show that MBD4 has a wide range of binding specificity, but prefers 
methylated and mismatched DNA sequence over hydroxymethylated and unmethylated CpGs. 
We propose that the MBD domain of MBD4 helps carry the glycosylase cargo to the appropriate 
mismatch DNA sites within mCpG islands. Also, the scanning mechanism of MBD domain of 
MBD4 while recognizing mCpG is discussed and this is the first time the hopping mechanism is 
demonstrated for MBD4 in targeting a relatively diverse DNA methylation mark. This study 
provides useful insights into protein-DNA recognition mechanism. Further studies involving 
various lengths of the linker DNA between two sites and diverse defects within the DNA are 
necessary to fully understand how MBD4 translocates on DNA while scanning for its target 
sites.  
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Chapter 3 
Solving the solution 
structure of MBD domain 
of MBD4 on methylated 
DNA by NMR. 
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3.1 Abstract 
Nuclear magnetic resonance (NMR) spectroscopy has emerged as a powerful tool for 
structural studies of biological macromolecules in solution. Over the years it has undergone 
dramatic developments in both instrument hardware and methodology making it one of the most 
complex and constantly evolving biophysical techniques. Different groups of researchers use 
widely different approaches and sets of experiments to derive get the final three dimensional 
structures. Here, I describe the workflow used in solving the solution structure of MBD domain 
of human MBD4 bound to a methylated DNA. After a brief introductory section that describes 
overall process and pipeline strategy, NMR sample preparation, data analysis and structure 
calculation will be discussed. The section on NMR sample preparation describes an overall 
sample preparation strategy used in making labeled proteins which often is crucial and can be a 
bottleneck for the success of NMR project. Later, experiments collected for resonance 
assignment of backbone atoms and side-chain atoms are briefly described. How to extract 
structural restraints to use in NMR structure calculation are explained. The final structure is 
calculated by simulated annealing using the XPLOR-NIH software package. 
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3.2 Introduction 
3.2.1 NMR spectroscopy in structural biology  
Knowing the three-dimensional structure of a protein has always been insightful in 
understanding its biological function and mechanism of action. As of May 8, 2013, there are 
90,424 structures deposited in protein data bank (PDB), out of which 79,970 (~88.5%) were 
solved with X-ray crystallography methods, 9,944 (~11.0%) with NMR spectroscopy methods 
and the one remaining with the help of electron microscopy. Although X-ray crystallography 
remains dominant, NMR spectroscopy is the only biophysical technique that can study dynamics 
and determine three dimensional (3D) structures in solution. Structural information provided by 
NMR spectroscopy can add to already existing information based on a crystal structure; NMR 
methods are sometimes used for refining existing x-ray structures. Along with these advantages, 
NMR also has few drawbacks; the main limitation of solution NMR spectroscopy is a limitation 
on the size of the molecule being investrigated. Larger protein spectra not only lead to significant 
resolution problems due to overlapping signals, but also face severe broadening of signals since 
larger molecule tumbles slowly in solution. This in turn leads to an increase of relaxation 
processes and thereby affecting overall resolution. Development of cryo-probes and high field 
strength magnets help with another drawback of NMR: insensitivity. Despite these shortcomings, 
NMR spectroscopy remains a great tool for studying 3D structures and dynamics. Here, we use 
NMR spectroscopy to solve the solution structure of the MBD domain on MBD4 bound to a 
DNA. 
3.2.2 NMR spectroscopy pipeline for protein structure determination  
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Even today, NMR protein structure determination remains a tedious, costly and time 
consuming process. Figure 3.1 enlists standard processes involved in NMR structure 
determination pipeline. Target selection and cloning the most feasible region for study is a 
relative straightforward but crucial step and can have a huge impact on the success of the NMR 
experiments. Overexpression of labeled protein can be easily achieved with the help of standard 
molecular biology techniques. Making a labeled protein and screening the quality of the sample 
is described in section 3.3. Once you have a necessary quantity of a pure and stable protein, the 
next step of collecting NMR spectra is purely physical and depends on concentration of sample 
and NMR spectrometer. The set of experiments collected depends on the information being 
sought. All experiments were collected on Bruker Avance III
TM 
700MHz NMR spectrometers at 
25
0
C. Initial data processing was done on Topspin
TM
, software provided by Bruker. The more 
powerful and widely used software NMRPipe (1), a script based NMR spectral processing and 
analysis package, was used for data processing. The CCPNMR analysis software (2) was used for 
displaying spectra, analyzing, peak picking, resonance assignments and NOE picking. The 
assignment process is briefly described in section 3.4. Later chapters discuss the process of 
structure determination. NOE distance restraints exported from CCPNMR and torsion angle 
restraints calculated using TALOS+ (3) were used for structure calculation by simulated 
annealing using the XPLOR-NIH software package (4). With MBD4, pertinent steps are briefly 
described and resulting 3D structure is shown. 
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Figure 3.1: Standard process of NMR structure determination.  
  
88 
 
3.3 NMR sample preparation 
3.3.1 General considerations 
NMR is an inherently insensitive technique and also has a size limitation (< 40kD), thereby 
making the choice of protein construct under study very critical. The smaller and more stable the 
domain chosen for structure determination, the easier it is to get higher concentrations and better 
signal. On several occasions, researchers have found that sample preparation is the bottleneck to 
the structure determination and can be costly and time consuming. In x-ray crystallography, 
getting a good quality diffracting crystal is a challenging stage. But, in NMR, use of expensive 
isotopes (
13
C, 
15
N, 
2
H) add cost and warrant a need for growing protein expressing bacteria in 
minimal media which can affect the final yield. Also, NMR experiments are conducted over 
longer periods (weeks) at room temperature (unless cryo-magnets are used), making the sample 
susceptible to degradation. Therefore, an extremely pure and stable sample is needed for 
structure determination. 
 3.3.2 Overexpression of Isotope labeled MBD4.  
The MBD domain of human MBD4 (Figure 2.1) is a well-defined domain and known to 
bind a methylated CpG containing DNA (5). The MBD domain was cloned as explained in 
section 2.3.1 keeping in mind that no unnecessary amino acids will be added to the final protein, 
thereby keeping the overall complex as small as possible. A minimal medium with defined 
nitrogen and carbon sources was used for making uniformly labeled protein. Bacteria containing 
the plasmid were grown on 
15
NH4Cl and 
13
C-glucose to have 
15
N and 
13
C labeled protein. The 
recipe for minimal media (M9) is listed in Table 3.1. 
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With MBD4, bacteria containing MBD4 expression vector were streaked on Luria Bertani 
(LB) agar plate. Streak of these bacteria was used to inoculate 1 ml of LB media for several 
hours. When turbid, only 100 µL of this was added to 2 ml M9 media and incubated at 37
0
C until 
the cells entered log phase. This 2ml was used as inoculum for 10ml and then 50 ml M9 media 
for overnight growth at 37
0
C. This was used to inoculate 1L M9 and was grown until OD600 
reached 0.8. It was then induced with 1mM IPTG for 4 hours and harvested as described in 2.3.1. 
To make 
2
H labeled sample, all sources of H2O were avoided and sample was grown in heavy 
water (
2
H2O). The bacterial doubling time in M9 is slower than in enriched media like LB, and it 
slows down further when heavy water is used for making triple labeled proteins. The protein 
purification process was optimized and is described in 2.3.1. 
A 10 base pair oligonucleotide with one centrally methylated CpG (Table 2.1) was used as 
a binding partner for MBD4 and was purified as described in 2.3.2. The MBD domain was added 
to DNA at 1:1.1 ratio (10% excess DNA) and then buffer exchanged into 10 mM NaPO4, pH 6.5, 
1 mM dithiothreitol, 10% D2O and 0.02% sodium azide. At least 0.5 ml of this mixture at 
concentration of 200 µM was added to a regular NMR tube and the quality of the sample was 
tested using 
15
N-HSQC. 
3.3.3 NMR sample screening with 1H-15N-HSQC experiment. 
1
H-
15
N-HSQC is the most standard 2D heteronuclear experiment and requires at least 
15
N 
labeling. Magnetization is transferred from a proton to attached 
15
N nuclei via J-coupling. 
Chemical shift is evolved on nitrogen and then transferred back to the more sensitive proton for 
detection. This experiment shows all N-H pairs, mainly amide in a peptide bond. The HSQC 
spectrum contains a cross peak for each backbone amide group (except Pro), the NH2 side chain 
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groups of Asn & Gln and the aromatic NH groups of Trp. The NƐHƐ of Arg is also visible, but 
chemical shift generally lies outside the area usually covered (103 ppm -133ppm for MBD4) by 
the HSQC spectrum. A wide spectral width (103 ± 30 ppm in the case of MBD4) was used to 
detect these ARG NƐHƐ resonances. A typical HSQC spectrum of MBD4 on a 10 bp DNA is 
shown in Figure 3.2.    
HSQC spectrum provides a footprint of each protein and provides an overall idea about the 
nature of the protein under study. A widely spread HSQC spectrum indicates that protein is 
folded, more likely to be stable and worth pursuing further structure solving process.  Although it 
is not possible to assign cross peaks to specific residues using an HSQC alone, the spectrum 
provides valuable information about the quality of data to expect from a given sample. 
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Table 3.1: Recipe for 1L minimal medium (M9). 
 
H2O (D2O if needed) 970.0 ml 
KH2PO4  (Anhydrous) 13.0 g 
K2HPO4 (Anhydrous) 10.0 g 
Na2HPO4 (Anhydrous) 9.0 g 
K2SO4 (Anhydrous) 2.4 g 
NH4Cl (
15
N-labeled if needed) 1.0 g 
D-Glucose (
13
C-labeled if needed) 3.0-5.0 g 
Dissolve and sterile filter above and add below 
Trace Elements 10.0 ml 
           
 
 Trace Elements Recipe per 100ml H2O 
         FeSO4 (7H2O) 0.60 g  
 CaCl2 (2H2O) 0.60 g  
 MnCl2 (4H2O) 0.12 g  
 CoCl2 (6H2O) 0.08 g  
 ZnSO4 (7H2O) 0.07 g  
 CuCl2 (2H2O) 0.03 g  
 H3BO3 2 mg  
 (NH4)6 Mo7 O24 (4H2O) 0.025 g  
         EDTA 0.50 g 
Sterile filter. (lyophilize to remove water if 
needed) 
     
 
1M MgCl2 stock (powdered form if needed) 10.0 ml 
5 mg/ml Thiamine stock (powered form if needed) 6.0 ml 
100mg/ml ampicillin (appropriate antibiotic) 1.0 ml 
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Figure 3.2: 
1
H-
15
N-HSQC of MBD4 on methylated DNA. A peak for each backbone 
amide group (except Pro) is visible. The NH2 side chain groups of Asn & Gln are also 
visible and generally present in region circled in green. The aromatic NH groups of Trp 
are detected in region circled in red. The NƐHƐ of Arg is also visible but generally folded 
(circled in blue).  
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3.4 Resonance Assignment 
3.4.1 Backbone resonance assignment  
The protein backbone is comprised of H, N, CA, CB and C atoms and the assignment of 
the backbone resonances is a prerequisite for further investigation by NMR spectroscopy.  A 
series of heteronuclear experiments correlating inter and intra residual H, N, Cα, Cβ and C 
through scalar couplings along bonds are collected in uniformly 
13
C and 
15
N labeled proteins. 
This results in a set of sequential resonances corresponding to backbone atoms. Assigning these 
resonances to a particular amino acid in native sequence is a vital step in NMR protein structure 
determination. Typically, backbone resonance assignment is divided into three steps; forming 
spin systems, linking spin systems into fragments, and mapping the fragments to the target 
sequence. A spin system denotes a group of coupled nuclei that can be observed as cross-peaks 
in one or more spectra. Usually spin systems contain both inter-residue and intra-residue 
information. For MBD4, the set of experiments mentioned in Table 3.2 were collected and 
processed data were imported in CCPNMR. After initializing HSQC, peaks were picked in all 
spectra depending on correlation observed. The type and number of peaks expected from each 
spectra are mentioned in Table 3.2. This process results in list of resonances that are linked (i-1, 
i, i+1 etcetera). The Biological Magnetic Resonance data Bank (BMRB) has statistically 
calculated chemical shift possibilities for all atoms in 20 amino acids. Within CCPNMR; with 
the help of sequence specific assignment, resonance tables and distributions of chemical shifts by 
amino acid type as found in BMRB; resonances for backbone atoms can be linked and assigned 
to the native sequence. Backbone assignment is important as it provides the basic framework for 
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structure determination. Chemical shifts of backbone residues are also used for secondary 
structure prediction and thereby used in deriving angle restraints.  
3.4.2 Side-chain resonance assignment 
The assignment of side-chain resonances is the next step and depends on prior knowledge 
of the backbone spin system. A series of 3D experiments were collected and are listed in Table 
3.2. The CCHTOCSY experiments correlates all aliphatic 
1
H and 
13
C spins within residues and is 
used to assign all observable side-chain resonances to the backbone resonances. For larger 
proteins, CCHTOCSY spectra can be complicated due to overlap and more experiments are 
needed to sort through all peaks (Table 3.2). Prior knowledge of average chemical shifts for 
observable side chain protons is very helpful and is shown in Figure 3.3. Protons and carbons of 
aliphatic side-chain were assigned as mentioned above. For the assignment of aromatic side-
chain proton experiments HBCBCGCDHD and HBCBCGCHHDHE experiments were collected 
which correlate carbon CB to proton HD or HE of an aromatic side-chain. Also 
15
N-NOESY-
HSQC and 
13
C-NOESY-HSQC spectra can be used for resonance assignments with the 
assumption that protons close enough in space should be visible in these spectra. For detailed 
information about assignment procedures, please refer to a tutorial written by Victoria Higman 
(http://www.protein-nmr.org.uk/solution-nmr/assignment-theory/). For MBD4, almost all 
backbone residues were assigned and high percentage of side-chain resonances were assigned. 
All assignments are summarized in Table 3.3. Assignments of side-chain resonances are crucial 
as they are most likely to provide long distance NOE cross-peaks, thereby helping with three-
dimensional structure determination.    
  
95 
 
3.4.3 Assignment of NOESY cross-peaks 
After the complete assignments of backbone and side-chain resonances, 
15
N-NOESY-
HSQC and 
13
C-NOESY-HSQC spectra were collected. These correlate protons with N-H or C-H 
pair that are proximate in space. Assigning these complex spectra yields vital structural restraints 
used in structure determination.  In the initial stage of assignment, usually only a fraction of total 
NOESY cross-peaks are assigned, but additional NOESY peaks are assigned in later stages of 
structure calculations with a help of initial structural folds. 
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Table 3.2: Experiments utilized in backbone and side-chain resonance assignment. 
 
Experiments utilized in assignment of backbone atoms 
Experiment Name Dimension Peaks observed. 
1H-15N-HSQC 2 (15N,1H) Amide NH pairs, also side chains of Arg, Trp, 
Asn,Gln) 
HNCA 3 (13C, 1H, 15N) Strong  CA(i) and weak CA(i-1) 
HNCO 3 (13C, 1H, 15N) C (i-1) 
HNCACO 3 (13C, 1H, 15N) Strong C(i) and weak C(i-1) 
HNCACB 3 (13C, 1H, 15N) Strong CA(i), CB(i), and weak CA(i-1), CB (I-1) 
CBCACONH 3 (13C, 1H, 15N) CA (i-1) and CB (i-1) 
 
Experiments utilized in assignment of side-chain atoms 
Experiment Name Dimension Peaks observed. 
HBHACONH 3 (1H,1H,15N) HA (i-1) and HB (i-1) 
CCHTOCSY 3 (13C, 1H, 13C) CA (i), CB (i), CG (i), CD(i), CE(i) etcetera 
CDIPSI 3 (13C, 1H, 15N) CA(i-1), CB (i-1), CG (i-1), CD(i-1), CE(i-1) etcetera 
HDIPSI 3 (1H, 1H, 15N) HA (i-1), HB(i-1), HG(i-1), HD(i-1) etcetera 
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Figure 3.3: Average chemical shifts for observable side-chain protons of twenty amino acids.
98 
 
Table 3.3: Chemical shift table in ppm for backbone and side chain resonances of amino acids in MBD4. 
!                   H      N     HA        HB        HG     HD      C     CA     CB     CG     CD 
     79      S      -      -      -         -         -      - 174.96  58.54  64.01      -      - 
     80      T   8.34 115.66   4.38      4.29      1.22      - 174.57  62.14  69.64  21.31      - 
     81      E   8.43 123.11   4.33 1.97,2.05 2.27,2.33      - 176.12  56.67  30.26  36.34      - 
     82      C   8.39 120.92   4.48      2.90         -      - 174.34  58.46  27.99      -      - 
     83      R   8.48 124.15   4.37 1.90,1.79      1.63   3.21 176.14  56.27  30.86  27.10  43.31 
     84      K   8.41 122.77      -         -         -      - 176.56  55.97  33.33      -      - 
     85      S   8.44 118.29   4.41      3.81         -      - 173.67  58.35  63.93      -      - 
     86      V   8.28 123.63   4.29      2.10      1.10      -      -  60.18  33.38  21.79      - 
     87      P      -      -   4.20 2.04,1.47 1.16,0.59 3.45,2.68 175.67  63.62  32.04  27.25  51.04 
     88      C   8.39 120.99   4.24      2.98         -      - 176.34  61.16  26.92      -      - 
     89      G   9.01 115.99 4.41,3.78         -         -      - 174.17  45.44      -      -      - 
     90      W   8.41 121.61   4.99 3.45,3.28         -   7.26 175.33  57.49  29.51      - 127.19 131.31:Ne1   
10.48:He1    7.56:Hz2    6.81:Hz3    6.63:Hh2  114.39:Cz2  121.64:Cz3  124.29:Ch2  
     91      E   8.96 119.67   4.85 1.97,1.88 2.10,2.26      - 174.31  55.07  33.41  35.98      - 
     92      R   8.94 126.74      -         -         -      - 174.64  54.94  33.25      -      - 
     93      V   9.10 130.44   4.13      1.18 0.82,0.73      - 173.39  61.55  34.33 20.83,21.15      - 
     94      V   8.34 125.53   4.66      1.95      1.42      - 175.83  61.30  33.09  21.43      - 
     95      K   9.16 128.34   4.88 1.83,2.00 1.51,1.42   1.84 175.17  54.74  36.17  25.31  28.94   3.09:Hea    
3.16:Heb   42.21:Ce   
     96      Q   8.94 128.36   4.47      1.83 2.00,1.20      - 175.67  54.82  30.08  33.44      - 
     97      R   9.12 127.15   4.44 1.84,1.85      1.63 2.83,3.00 178.21  57.72  30.37  26.95  44.37 
     98      L   9.05 125.93   4.34 0.96,1.46      0.90   0.68 176.65  55.70  44.06  25.08  22.50 
     99      F   8.25 119.36   4.95 3.00,3.22         -   7.34 173.85  56.70  42.76      - 132.58 
    100      G   8.11 104.71 4.54,3.76         -         -      - 176.17  44.10      -      -      - 
    101      K   9.13 122.60   4.11      2.00 1.67,1.59   1.83 179.61  59.66  32.77  25.35  29.84   3.08:Hea   41.76:Ce   
    102      T   8.98 108.65   4.34      4.46      1.37      - 172.97  61.32  68.97  21.67      - 
    103      A   6.93 123.17   3.37      1.07         -      - 178.08  54.12  17.94      -      - 
    104      G   8.54 111.43 3.42,4.48         -         -      - 175.27  44.48      -      -      - 
    105      R   7.65 119.64      -         -         -      - 174.18  56.78  30.64      -      - 
    106      F   8.75 117.62   5.42 2.75,2.90         -      - 175.44  57.19  42.53      -      - 
    107      D   8.86 119.34   5.18 2.52,2.45         -      - 173.61  53.68  45.29      -      - 
    108      V   8.55 121.64   4.92      1.98 0.53,0.84      - 174.76  60.81  33.93 21.78,22.67      - 
    109      Y   8.89 121.62   5.42 3.02,2.90         -   6.89 173.43  55.46  42.04      - 133.36   6.66:He*  
118.03:Ce*  
    110      F   8.90 117.34   5.85 3.44,2.98         -      - 175.42  56.71  44.12      -      - 
    111      I   9.66 121.79   5.23      1.83 1.58,1.05,0.95   0.87 176.36  59.98  39.90 17.64,27.94  13.65 
    112      S   9.42 126.06   3.05 3.25,3.43         -      -      -  56.70  63.15      -      - 
    113      P      -      -   4.26 1.77,2.39 2.00,1.65 1.61,2.90 177.21  64.91  31.44  27.48  49.06 
    114      Q   7.17 112.29   4.38 2.25,1.81 2.46,2.37      - 175.99  55.82  28.65  34.59      - 
    115      G   8.15 108.91 4.15,3.43         -         -      - 174.16  45.32      -      -      - 
    116      L   7.17 121.03   4.18 1.08,1.42      1.29 0.88,0.83 175.19  54.77  42.54  27.56 23.33,25.22 
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Table 3.3 continued… 
 
    117      K   8.24 121.58   5.27 1.52,1.66 1.23,1.42 1.40,1.56 175.98  55.43  34.56  26.14  29.49   2.73:Hea   
41.73:Ce   
    118      F   9.64 121.82   4.91 3.27,3.09         -      - 176.45  58.01  42.98      -      - 
    119      R   9.59 119.54   5.11 2.02,2.12      1.56   3.13 174.70  55.17  31.82  27.43  43.96 
    120      S   7.62 110.78   4.34 3.44,3.94         -      - 172.79  56.03  66.49      -      - 
    121      K   8.82 125.44   3.64 1.80,1.62 1.39,1.45   1.77 178.83  59.65  31.15  25.06  29.22 
    122      S   8.83 115.39      -         -         -      - 177.43  61.35  62.34      -      - 
    123      S   8.04 118.25      -         -         -      - 178.02  61.62  63.07      -      - 
    124      L   7.69 126.77   3.65 1.40,1.62      0.81 -0.36,-0.11 177.99  58.30  42.31  27.19 24.33,23.97 
    125      A   8.91 121.66   3.69      1.44         -      - 180.03  55.69  17.88      -      - 
    126      N   7.96 115.71   4.50 2.96,2.98         -      - 177.17  56.37  38.52      -      - 
    127      Y   7.75 121.60   4.29 3.41,3.07         -   7.08 177.89  61.58  39.05      - 133.71   6.97:He*  
118.19:Ce*  
    128      L   8.60 119.36   3.80 1.73,1.43      1.83 0.82,0.42 179.42  57.75  40.89  26.31 25.39,21.94 
    129      H   8.04 115.99   4.51      3.31         -      - 178.01  58.09  29.35      -      - 
    130      K   8.14 119.80   4.08 1.88,1.92 1.55,1.50   1.72 177.32  58.36  32.57  25.01  29.19   3.04:Hea   42.02:Ce   
    131      N   7.66 115.91   4.66 2.67,2.27         -      - 175.34  53.59  39.28      -      - 
    132      G   7.85 108.48   3.91         -         -      - 174.65  46.33      -      -      - 
    133      E   8.14 120.05   4.36 2.05,2.10      2.30      - 177.32  56.71  29.89  36.54      - 
    134      T   8.36 114.99   4.36      4.38      1.22      - 174.93  62.08  69.98  21.71      - 
    135      S   8.58 118.37      -         -         -      - 174.28  59.51  63.81      -      - 
    136      L   8.05 123.00   4.46 1.67,1.34      0.93   0.78 175.10  54.52  44.47  25.75  23.50 
    137      K   8.79 121.09   4.77 1.82,1.70      1.68   1.67      -  53.13  33.23  24.78  28.87   2.96:Hea    
2.98:Heb   41.89:Ce   
    138      P      -      -   3.96 2.10,1.99 2.31,1.76 3.71,3.87 177.65  66.04  31.47  28.31  49.98 
    139      E   8.89 113.38   4.14 2.04,1.97 2.32,2.26      - 176.69  58.77  28.53  36.89      - 
    140      D   8.03 119.52   4.30 2.21,2.54         -      - 174.54  55.91  40.87      -      - 
    141      F      -      -      -         -         -   6.05      -      -      -      -      - 
    141      F   7.54 118.83   3.87 2.75,1.75         -      - 173.52  57.27  39.48      - 132.01 
    142      D   8.54 122.73      -         -         -      - 176.42  53.72  41.68      -      - 
    143      F   9.41 127.53   4.51 3.57,3.10         -   7.41 174.88  59.00  39.50      - 132.59 
    144      T   8.36 114.74   4.59      4.27      1.30      -      -  62.52  70.26  21.46      - 
    145      V      -      -   4.00      1.98 0.90,0.65      - 176.10  62.70  32.59 21.19,21.27      - 
    146      L   8.08 124.46   4.37 1.56,1.62      1.58 0.92,0.85 176.92  54.96  42.44  27.02 24.70,23.65 
    147      S   8.22 117.56      -         -         -      - 173.42  58.23  63.95      -      - 
    148      K   7.96 128.34   4.16 1.81,1.69 1.36,1.38   1.68      -  57.72  33.75  24.69  29.06   2.96:Hea    
2.99:Heb   41.93:Ce 
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3.5 Structural parameters for NMR  
Several of NMR experiments generate structural restraints used for structure calculations. 
The most widely used restraints are inter-proton distances measured by NOE, Hydrogen bond 
restraints predicted from secondary structure and backbone torsion angles defined by chemical 
shift analysis. Orientation restraints generated by residual dipolar coupling (RDC) are not 
required but are being used much more commonly.  
3.5.1 Hydrogen bond restrains  
Protein secondary structures (α helix or β sheet) are well studied and are known to exhibit 
geometrically driven hydrogen bonding. In the case of an α helix, a linear hydrogen bond is set 
between the amide proton and the oxygen of carboxyl group of (n-4)
th
 amino acid. In the case of 
a β sheet, hydrogen bonding exists between two parallel or anti-parallel strands. This information 
is very useful and can have a large impact on accuracy of final resulting structure. Hydrogen 
bonding information is taken only from region with well-defined secondary structure. With 
MBD4, we defined one α helix and two anti-parallel β strands using TALOS+. 
TALOS+ breaks the sequence into overlapping amino acid triplicates and compares their 
chemical shifts with a database of homologous polypeptides with known torsion angles and 
chemical shifts. It predicts backbone torsion angles based on their chemical shift. Chemical shift 
data from CCPNMR was exported using format converter tool. The format used for TALOS+ 
calculation is shown in Table 3.4. TALOS+ predictions of backbone torsion angles and 
secondary structure for each residue were calculated. The Degree of prediction accuracy is 
depicted in green (good), yellow (ambiguous) and blue (dynamic) in Figure3.4. 
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Table 3.4: A chemical shifts table for TALOS+. (Note that residue ID starts from 1.) 
REMARK File written by CcpNmrFormat converter. 
DATA FIRST_RESID  1 
DATA SEQUENCE GSTECRKSVP CGWERVVKQR LFGKTAGRFD VYFISPQGLK FRSKSSLANY 
DATA SEQUENCE LHKNGETSLK PEDFDFTVLS K 
 
VARS   RESID RESNAME ATOMNAME SHIFT 
FORMAT %4d %1s %4s %8.3f 
 
   2 S    C  174.960 
   2 S   CA   58.539 
   2 S   CB   64.005 
   3 T    C  174.574 
   3 T   CA   62.185 
   3 T   CB   69.650 
   3 T  CG2   21.358 
   3 T   HN    8.340 
   3 T   HA    4.374 
   3 T   HB    4.279 
   3 T    N  115.664 
   3 T HG2#    1.219 
   4 E    C  176.123 
   4 E   CA   56.672 
   4 E   CB   30.260 
   4 E   CG   36.338 
   4 E   HN    8.432 
   4 E   HA    4.327 
   4 E  HB2    2.055 
   4 E  HB1    1.975 
   4 E  HG2    2.328 
   4 E  HG1    2.269 
   4 E    N  123.107 
   5 C    C  174.341 
   5 C   CA   58.546 
   5 C   CB   27.941 
   5 C   HN    8.392 
   5 C   HA    4.486 
   5 C  HB1    2.899 
   5 C    N  120.920 
   6 R    C  176.140 
   6 R   CA   56.215 
   6 R   CB   30.862 
   6 R   CD   43.339 
   6 R   CG   27.099 
   6 R   HN    8.478 
   6 R   HA    4.386 
   6 R  HB2    1.788 
   6 R  HB1    1.901 
   6 R  HD1    3.211 
   6 R  HG1    1.635 
   6 R    N  124.149 
   7 K    C  176.555 
INCOMPLETE 
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Figure 3.4: TALOS+ analysis for MBD4. Backbone torsion angles (ψ and φ) are 
predicted using chemical shifts. Predicted secondary structures are shown in blue (β 
strands) and red (α helices). 
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Secondary structures predicted by TALOS+ can be seen in Figure 3.4. Three β strands 
(blue and positive) and two α helices (red and negative) are predicted by TALOS+. NOE data 
were used to confirm the secondary structure predictions. The short β strand and α helix were not 
included in the structure calculation, thereby using only two strands (91E-99F, 106E-111I) and 
one helix (121K-130K) for generating structural restraints. Hydrogen bond distance and 
Hydrogen bond distance angle tables were generated for structured residues and are listed in 
Table 3.5 and Table 3.6.  
3.5.2 Torsion angle restraints 
Proteins have backbone dihedral angles (φ, ψ, ω) and side chain dihedral angles (χ1-2-3…) 
and are depicted in Figure 3.5. Torsion angles can be determined from several J scalar coupling 
interactions between atoms and they provide geometric information between atoms in a 
molecule. TALOS+ analysis predicts psi and phi torsion angles which range from -180
0
 to + 
180
0. Torsion angle ω is approximately equal to 1800 or 00 because of the planer nature of 
peptide bond so it is not often measured.  The φ and ψ angles from well predicted residues 
(shown in green, Figure 3.4) are used for structure calculation. The format for the table is shown 
in Table 3.7.  Additional scalar coupling experiments are conducted to determine the side-chain 
torsion angles. Experiments HNCG_ARO and HNCOCG_ARO are used to measure χ1 for F, W, 
Y and H amino acids. Side chain torsion angles are typically near 180
0
 (trans), 60
0 
(gauche+) and 
-60
0
 (gauche-). A side-chain torsion angle table was generated and these parameters were used as 
structural restraints (Table 3.8).  
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Figure 3.5: Torsion angles φ, ψ, ω and χ1 in proteins.  
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Table 3.5: Hydrogen bond table. Hydrogen bond restraints are defined based on TALOS+ 
prediction of secondary structures. 
hb_alpha.tbl 
assign (resid 121 and name O )(resid 125 and name HN ) 2.3 1.0 0.2 
 assign (resid 121 and name O )(resid 125 and name N ) 3.3 1.0 0.2 
 
assign (resid 122 and name O )(resid 126 and name HN ) 2.3 1.0 0.2 
 assign (resid 122 and name O )(resid 126 and name N ) 3.3 1.0 0.2 
 
assign (resid 123 and name O )(resid 127 and name HN ) 2.3 1.0 0.2 
 assign (resid 123 and name O )(resid 127 and name N ) 3.3 1.0 0.2 
 
assign (resid 124 and name O )(resid 128 and name HN ) 2.3 1.0 0.2 
 assign (resid 124 and name O )(resid 128 and name N ) 3.3 1.0 0.2 
 
assign (resid 125 and name O )(resid 129 and name HN ) 2.3 1.0 0.2 
 assign (resid 125 and name O )(resid 129 and name N ) 3.3 1.0 0.2 
 
assign (resid 126 and name O )(resid 130 and name HN ) 2.3 1.0 0.2 
 assign (resid 126 and name O )(resid 130 and name N ) 3.3 1.0 0.2 
 
hb_beta.tbl 
assign (resid 91 and name O )(resid 111 and name HN ) 2.3 1.0 0.2 
 assign (resid 91 and name O )(resid 111 and name N ) 3.3 1.0 0.2 
assign (resid 111 and name O )(resid 91 and name HN ) 2.3 1.0 0.2 
 assign (resid 111 and name O )(resid 91 and name N ) 3.3 1.0 0.2 
 
assign (resid 93 and name O )(resid 109 and name HN ) 2.3 1.0 0.2 
 assign (resid 93 and name O )(resid 109 and name N ) 3.3 1.0 0.2 
assign (resid 109 and name O )(resid 93 and name HN ) 2.3 1.0 0.2 
 assign (resid 109 and name O )(resid 93 and name N ) 3.3 1.0 0.2 
 
assign (resid 95 and name O )(resid 107 and name HN ) 2.3 1.0 0.2 
 assign (resid 95 and name O )(resid 107 and name N ) 3.3 1.0 0.2 
assign (resid 107 and name O )(resid 95 and name HN ) 2.3 1.0 0.2 
 assign (resid 107 and name O )(resid 95 and name N ) 3.3 1.0 0.2 
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Table 3.6: Hydrogen bond distance angle table. Hydrogen bond distance angles restraints are 
defined based on TALOS+ prediction of secondary structures. 
 
hbda_alpha.tbl 
 
assign (resid 125 and name n)(resid 125 and name hn)(resid 121 and name o) 
 
assign (resid 126 and name n)(resid 126 and name hn)(resid 122 and name o) 
 
assign (resid 127 and name n)(resid 127 and name hn)(resid 123 and name o) 
 
assign (resid 128 and name n)(resid 128 and name hn)(resid 124 and name o) 
 
assign (resid 129 and name n)(resid 129 and name hn)(resid 125 and name o) 
 
assign (resid 130 and name n)(resid 130 and name hn)(resid 126 and name o) 
 
 
hbda_beta.tbl 
 
assign (resid 91 and name n)(resid 91 and name hn)(resid 111 and name o) 
assign (resid 111 and name n)(resid 111 and name hn)(resid 91 and name o) 
 
assign (resid 93 and name n)(resid 93 and name hn)(resid 109 and name o) 
assign (resid 109 and name n)(resid 109 and name hn)(resid 93 and name o) 
 
assign (resid 95 and name n)(resid 95 and name hn)(resid 107 and name o) 
assign (resid 107 and name n)(resid 107 and name hn)(resid 95 and name o) 
 
 
  
107 
 
Table 3.7: Backbone dihedral angle restraint table. Generated using TALOS+ for Phi (φ) and Psi 
(ψ) angles. Information from only well predicted residues is used. Rests are commented out. 
! talos_pred2xplor.nawk Table !   Date: Fri Jan 25 15:48:39 EST 2013 
!   Path: /Users/ninadmw/StructureCalc/MBD4/TALOS+_10bp 
! 
! G78 Dihedrals 
 
! S79 Dihedrals 
!assign (resid  78 and name c)  (resid  79 and name n) 
!       (resid  79 and name ca) (resid  79 and name c)  1.0  -72.4  84.4 2      ! S79 Talos Phi 
!assign (resid  79 and name n)  (resid  79 and name ca) 
!       (resid  79 and name c) (resid  80 and name n)  1.0  103.7  58.0 2      ! S79 Talos Psi 
 
! T80 Dihedrals 
!assign (resid  79 and name c)  (resid  80 and name n) 
!       (resid  80 and name ca) (resid  80 and name c)  1.0  -95.3  42.6 2      ! T80 Talos Phi 
!assign (resid  80 and name n)  (resid  80 and name ca) 
!       (resid  80 and name c) (resid  81 and name n)  1.0   -9.2  28.1 2      ! T80 Talos Psi 
 
! E81 Dihedrals 
!assign (resid  80 and name c)  (resid  81 and name n) 
!       (resid  81 and name ca) (resid  81 and name c)  1.0  -73.7  73.5 2      ! E81 Talos Phi 
!assign (resid  81 and name n)  (resid  81 and name ca) 
!       (resid  81 and name c) (resid  82 and name n)  1.0  135.8  23.3 2      ! E81 Talos Psi 
 
! C82 Dihedrals 
!assign (resid  81 and name c)  (resid  82 and name n) 
!       (resid  82 and name ca) (resid  82 and name c)  1.0  -82.5  57.5 2      ! C82 Talos Phi 
!assign (resid  82 and name n)  (resid  82 and name ca) 
!       (resid  82 and name c) (resid  83 and name n)  1.0  117.7  22.6 2      ! C82 Talos Psi 
 
! R83 Dihedrals 
!assign (resid  82 and name c)  (resid  83 and name n) 
!       (resid  83 and name ca) (resid  83 and name c)  1.0  -74.5  69.7 2      ! R83 Talos Phi 
!assign (resid  83 and name n)  (resid  83 and name ca) 
!       (resid  83 and name c) (resid  84 and name n)  1.0  126.5  40.1 2      ! R83 Talos Psi 
 
! K84 Dihedrals 
!assign (resid  83 and name c)  (resid  84 and name n) 
!       (resid  84 and name ca) (resid  84 and name c)  1.0  -87.6  76.5 2      ! K84 Talos Phi 
!assign (resid  84 and name n)  (resid  84 and name ca) 
!       (resid  84 and name c) (resid  85 and name n)  1.0  130.0  44.1 2      ! K84 Talos Psi 
 
! S85 Dihedrals 
!assign (resid  84 and name c)  (resid  85 and name n) 
!       (resid  85 and name ca) (resid  85 and name c)  1.0  -79.0  57.3 2      ! S85 Talos Phi 
!assign (resid  85 and name n)  (resid  85 and name ca) 
!       (resid  85 and name c) (resid  86 and name n)  1.0  131.5  22.1 2      ! S85 Talos Psi 
 
! V86 Dihedrals 
assign (resid  85 and name c)  (resid  86 and name n) 
       (resid  86 and name ca) (resid  86 and name c)  1.0  -89.8  51.2 2      ! V86 Talos Phi 
assign (resid  86 and name n)  (resid  86 and name ca) 
       (resid  86 and name c) (resid  87 and name n)  1.0  137.9  36.5 2      ! V86 Talos Psi 
 
! P87 Dihedrals 
assign (resid  86 and name c)  (resid  87 and name n) 
       (resid  87 and name ca) (resid  87 and name c)  1.0  -72.0  30.0 2      ! P87 Talos Phi 
assign (resid  87 and name n)  (resid  87 and name ca) 
       (resid  87 and name c) (resid  88 and name n)  1.0  156.2  20.5 2      ! P87 Talos Psi 
 
! C88 Dihedrals 
assign (resid  87 and name c)  (resid  88 and name n) 
       (resid  88 and name ca) (resid  88 and name c)  1.0  -70.0  32.1 2      ! C88 Talos Phi 
assign (resid  88 and name n)  (resid  88 and name ca) 
       (resid  88 and name c) (resid  89 and name n)  1.0  131.8  20.0 2      ! C88 Talos Psi 
 
! G89 Dihedrals 
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Table 3.7 continued… 
 
!assign (resid  88 and name c)  (resid  89 and name n) 
!       (resid  89 and name ca) (resid  89 and name c)  1.0   89.7  30.0 2      ! G89 Talos Phi 
!assign (resid  89 and name n)  (resid  89 and name ca) 
!       (resid  89 and name c) (resid  90 and name n)  1.0   -9.7  26.8 2      ! G89 Talos Psi 
 
! W90 Dihedrals 
!assign (resid  89 and name c)  (resid  90 and name n) 
!       (resid  90 and name ca) (resid  90 and name c)  1.0  -80.8  49.4 2      ! W90 Talos Phi 
!assign (resid  90 and name n)  (resid  90 and name ca) 
!       (resid  90 and name c) (resid  91 and name n)  1.0  132.6  60.0 2      ! W90 Talos Psi 
 
! E91 Dihedrals 
assign (resid  90 and name c)  (resid  91 and name n) 
       (resid  91 and name ca) (resid  91 and name c)  1.0 -129.2  30.0 2      ! E91 Talos Phi 
assign (resid  91 and name n)  (resid  91 and name ca) 
       (resid  91 and name c) (resid  92 and name n)  1.0  133.5  31.4 2      ! E91 Talos Psi 
 
! R92 Dihedrals 
assign (resid  91 and name c)  (resid  92 and name n) 
       (resid  92 and name ca) (resid  92 and name c)  1.0 -108.5  32.2 2      ! R92 Talos Phi 
assign (resid  92 and name n)  (resid  92 and name ca) 
       (resid  92 and name c) (resid  93 and name n)  1.0  117.7  20.0 2      ! R92 Talos Psi 
 
! V93 Dihedrals 
assign (resid  92 and name c)  (resid  93 and name n) 
       (resid  93 and name ca) (resid  93 and name c)  1.0 -121.0  30.0 2      ! V93 Talos Phi 
assign (resid  93 and name n)  (resid  93 and name ca) 
       (resid  93 and name c) (resid  94 and name n)  1.0  126.7  28.5 2      ! V93 Talos Psi 
 
! V94 Dihedrals 
assign (resid  93 and name c)  (resid  94 and name n) 
       (resid  94 and name ca) (resid  94 and name c)  1.0 -118.1  30.0 2      ! V94 Talos Phi 
assign (resid  94 and name n)  (resid  94 and name ca) 
       (resid  94 and name c) (resid  95 and name n)  1.0  126.7  20.0 2      ! V94 Talos Psi 
 
! K95 Dihedrals 
assign (resid  94 and name c)  (resid  95 and name n) 
       (resid  95 and name ca) (resid  95 and name c)  1.0 -122.5  38.0 2      ! K95 Talos Phi 
assign (resid  95 and name n)  (resid  95 and name ca) 
       (resid  95 and name c) (resid  96 and name n)  1.0  126.3  26.7 2      ! K95 Talos Psi 
 
! Q96 Dihedrals 
assign (resid  95 and name c)  (resid  96 and name n) 
       (resid  96 and name ca) (resid  96 and name c)  1.0 -105.1  39.3 2      ! Q96 Talos Phi 
assign (resid  96 and name n)  (resid  96 and name ca) 
       (resid  96 and name c) (resid  97 and name n)  1.0  116.9  25.8 2      ! Q96 Talos Psi 
 
! R97 Dihedrals 
!assign (resid  96 and name c)  (resid  97 and name n) 
!       (resid  97 and name ca) (resid  97 and name c)  1.0  -81.3  54.1 2      ! R97 Talos Phi 
!assign (resid  97 and name n)  (resid  97 and name ca) 
!       (resid  97 and name c) (resid  98 and name n)  1.0  126.6  40.9 2      ! R97 Talos Psi 
 
 
INCOMPLETE 
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Table 3.8: Side-chain dihedral angle (CHI (χ)) restraint table. Generated for χ1 angle for F, W, Y 
and H (highlighted in red).  
!Xplor Dihed Table from make_chi_xplr.nawk 
! USER  ninadmw 
! DATE  Sun Jan 27 13:48:26 EST 2013 
! PATH  /Users/ninadmw/StructureCalc/MBD4/CONSTRAINTS/DIHED 
 
 
! S79 Chi-1 
!assign (resid  79 and name n  ) (resid  79 and name ca ) 
!       (resid  79 and name cb ) (resid  79 and name og )  1.0    0.0   20.0 2 
 
! T80 Chi-1 
!assign (resid  80 and name n  ) (resid  80 and name ca ) 
!       (resid  80 and name cb ) (resid  80 and name og1)  1.0    0.0   20.0 2 
 
! E81 Chi-1 
!assign (resid  81 and name n  ) (resid  81 and name ca ) 
!       (resid  81 and name cb ) (resid  81 and name cg )  1.0    0.0   20.0 2 
 
! C82 Chi-1 
!assign (resid  82 and name n  ) (resid  82 and name ca ) 
!       (resid  82 and name cb ) (resid  82 and name sg )  1.0    0.0   20.0 2 
 
! R83 Chi-1 
!assign (resid  83 and name n  ) (resid  83 and name ca ) 
!       (resid  83 and name cb ) (resid  83 and name cg )  1.0    0.0   20.0 2 
! R83 Chi-2 
!assign (resid  83 and name ca ) (resid  83 and name cb ) 
!       (resid  83 and name cg ) (resid  83 and name cd )  1.0    0.0   30.0 2 
 
! K84 Chi-1 
!assign (resid  84 and name n  ) (resid  84 and name ca ) 
!       (resid  84 and name cb ) (resid  84 and name cg )  1.0    0.0   20.0 2 
! K84 Chi-2 
!assign (resid  84 and name ca ) (resid  84 and name cb ) 
!       (resid  84 and name cg ) (resid  84 and name cd )  1.0    0.0   30.0 2 
 
! S85 Chi-1 
!assign (resid  85 and name n  ) (resid  85 and name ca ) 
!       (resid  85 and name cb ) (resid  85 and name og )  1.0    0.0   20.0 2 
 
! V86 Chi-1 
!assign (resid  86 and name n  ) (resid  86 and name ca ) 
!       (resid  86 and name cb ) (resid  86 and name cg1)  1.0    0.0   20.0 2 
 
! P87 Chi-1 
!assign (resid  87 and name n  ) (resid  87 and name ca ) 
!       (resid  87 and name cb ) (resid  87 and name cg )  1.0    0.0   20.0 2 
 
! C88 Chi-1 
!assign (resid  88 and name n  ) (resid  88 and name ca ) 
!       (resid  88 and name cb ) (resid  88 and name sg )  1.0    0.0   20.0 2 
 
 
! W90 Chi-1 
!assign (resid  90 and name n  ) (resid  90 and name ca ) 
!       (resid  90 and name cb ) (resid  90 and name cg )  1.0    -60.0   20.0 2 
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! E91 Chi-1 
!assign (resid  91 and name n  ) (resid  91 and name ca ) 
!       (resid  91 and name cb ) (resid  91 and name cg )  1.0    0.0   20.0 2 
 
! R92 Chi-1 
!assign (resid  92 and name n  ) (resid  92 and name ca ) 
!       (resid  92 and name cb ) (resid  92 and name cg )  1.0    0.0   20.0 2 
! R92 Chi-2 
!assign (resid  92 and name ca ) (resid  92 and name cb ) 
!       (resid  92 and name cg ) (resid  92 and name cd )  1.0    0.0   30.0 2 
 
! V93 Chi-1 
!assign (resid  93 and name n  ) (resid  93 and name ca ) 
!       (resid  93 and name cb ) (resid  93 and name cg1)  1.0    0.0   20.0 2 
 
! V94 Chi-1 
!assign (resid  94 and name n  ) (resid  94 and name ca ) 
!       (resid  94 and name cb ) (resid  94 and name cg1)  1.0    0.0   20.0 2 
 
! K95 Chi-1 
!assign (resid  95 and name n  ) (resid  95 and name ca ) 
!       (resid  95 and name cb ) (resid  95 and name cg )  1.0    0.0   20.0 2 
! K95 Chi-2 
!assign (resid  95 and name ca ) (resid  95 and name cb ) 
!       (resid  95 and name cg ) (resid  95 and name cd )  1.0    0.0   30.0 2 
 
! Q96 Chi-1 
!assign (resid  96 and name n  ) (resid  96 and name ca ) 
!       (resid  96 and name cb ) (resid  96 and name cg )  1.0    0.0   20.0 2 
 
! R97 Chi-1 
!assign (resid  97 and name n  ) (resid  97 and name ca ) 
!       (resid  97 and name cb ) (resid  97 and name cg )  1.0    0.0   20.0 2 
! R97 Chi-2 
!assign (resid  97 and name ca ) (resid  97 and name cb ) 
!       (resid  97 and name cg ) (resid  97 and name cd )  1.0    0.0   30.0 2 
 
! L98 Chi-1 
!assign (resid  98 and name n  ) (resid  98 and name ca ) 
!       (resid  98 and name cb ) (resid  98 and name cg )  1.0    0.0   20.0 2 
! L98 Chi-2 
!assign (resid  98 and name ca ) (resid  98 and name cb ) 
!       (resid  98 and name cg ) (resid  98 and name cd1)  1.0    0.0   30.0 2 
 
! F99 Chi-1 
!assign (resid  99 and name n  ) (resid  99 and name ca ) 
!       (resid  99 and name cb ) (resid  99 and name cg )  1.0    -60.0   20.0 2 
! F99 Chi-2 
!assign (resid  99 and name ca ) (resid  99 and name cb ) 
!       (resid  99 and name cg ) (resid  99 and name cd1)  1.0    0.0   30.0 2 
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3.5.3 Inter-proton distances 
Inter-proton distances are the most important NMR structural restraints for structure 
determination because they provide both long-range and short-range distance information. Inter-
proton distances are usually measured with multi-dimensional NOESY (
15
N-NOESY-HSQC and 
13
C-NOESY-HSQC) spectra where the Nuclear Overhausar Effect (NOE) provides correlation 
between pair of protons which are separated by less than 5Å. Short-range NOEs are useful for 
confirming secondary structure elements such as α-helix and β-sheet. Long-range NOEs provide 
crucial tertiary structure information. The intensity of the NOE cross peak is inversely 
proportional to the sixth power of the distance between the two protons. A weaker NOE cross 
peak can also result from chemical exchange or dynamics in proteins. Therefore, weaker peaks 
can also be seen between protons that are closer than 4Å, while, a stronger peak is indicative of 
two protons close in space. Within CCPNMR, NOE cross peaks were assigned and intensities of 
the peaks were recorded which were used to determine qualitative distance restraints to be used 
for the structure calculation. Cross peak intensities (heights) were grouped into four different 
categories: 1.8Å-2.5Å (strong), 1.8Å-3.8Å
 
(medium), 1.8Å-5.0Å (weak) and 1.8Å – 6.0Å (very 
weak). NOE tables from 
15
N and 
13
C NOE experiments were merged, duplicates were removed 
and the format was adjusted for XPLOR calculations. The NOE table with more than 800 NOEs 
for MBD4 is shown in Table 3.9. Generally, ten NOEs per amino acid residue is enough for the 
structure determination. 
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Table 3.9: A combined NOE table. Both 
13
C and 
15
N NOE are demonstrated. 
!15N NOE 
assi    ((   resid 81   and name  HB# ))   ((   resid 82   and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((   resid 82   and name  HN  ))   ((   resid 82   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((   resid 83   and name  HN  ))   ((   resid 82   and name  HB# ))      4.000     2.200     1.000 
 
 assi    ((   resid 83   and name  HN  ))   ((   resid 82   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((   resid 83   and name  HB# ))   ((   resid 83   and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((   resid 83   and name  HN  ))   ((   resid 83   and name  HG# ))      4.000     2.200     1.000 
 
 assi    ((   resid 83   and name  HB# ))   ((   resid 85   and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((   resid 85   and name  HA  ))   ((   resid 85   and name  HN  ))      3.500     1.700     0.300 
 
 assi    ((   resid 85   and name  HN  ))   ((   resid 85   and name  HB# ))      4.000     2.200     1.000 
 
 assi    ((   resid 85   and name  HB# ))   ((   resid 148  and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((   resid 86   and name  HN  ))   ((   resid 85   and name  HB# ))      4.000     2.200     1.000 
 
 assi    ((   resid 86   and name  HN  ))   ((   resid 85   and name  HA  ))      3.500     1.700     0.300 
 
 assi    (    resid 86   and name  HG*)   ((   resid 86   and name  HN  ))      3.500     1.700     0.300 
 
 assi    ((   resid 86   and name  HN  ))   ((   resid 86   and name  HA  ))      4.000     2.200     1.000 
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!
13
C NOE 
 assi    (   resid 80   and name  HG2#)   ((  resid 80   and name  HB  ))      4.000     2.200     1.000 
 
 assi    (   resid 80   and name  HG2#)   ((  resid 80   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 80   and name  HA  ))   ((  resid 81   and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((  resid 82   and name  HB# ))   ((  resid 82   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 83   and name  HN  ))   ((  resid 82   and name  HA  ))      4.000     2.200     1.000 
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Table 3.9 continued… 
 
 assi    ((  resid 84   and name  HN  ))   ((  resid 83   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 85   and name  HA  ))   ((  resid 85   and name  HB# ))      3.500     1.700     0.300 
 
 assi    ((  resid 85   and name  HB# ))   ((  resid 148  and name  HN  ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 86   and name  HB  ))      3.500     1.700     0.300 
 
 assi    (   resid 86   and name  HG*)   ((  resid 86   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 86   and name  HN  ))   ((  resid 86   and name  HB  ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 86   and name  HB  ))      3.500     1.700     0.300 
 
 assi    ((  resid 86   and name  HA  ))   ((  resid 86   and name  HB  ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 86   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 86   and name  HA  ))   ((  resid 87   and name  HD# ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 87   and name  HD# ))      4.000     2.200     1.000 
 
 assi    ((  resid 86   and name  HA  ))   ((  resid 87   and name  HD# ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 87   and name  HD# ))      4.000     2.200     1.000 
 
 assi    ((  resid 86   and name  HA  ))   ((  resid 87   and name  HD# ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 90   and name  HB# ))      4.000     2.200     1.000 
 
 assi    (   resid 86   and name  HG*)   ((  resid 91   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 88   and name  HN  ))   ((  resid 82   and name  HB# ))      4.000     2.200     1.000 
 
 assi    ((  resid 88   and name  HA  ))   ((  resid 82   and name  HB# ))      4.000     2.200     1.000 
 
 assi    ((  resid 88   and name  HA  ))   ((  resid 88   and name  HN  ))      4.000     2.200     1.000 
 
 assi    ((  resid 89   and name  HN  ))   ((  resid 88   and name  HA  ))      4.000     2.200     1.000 
 
 assi    ((  resid 89   and name  HA# ))   ((  resid 113  and name  HG# ))      4.000     2.200     1.000 
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3.6 Structure calculation using XPLOR-
NIH 
Xplor-NIH is a package used for NMR structure calculations using experimental NMR data 
constraints and known geometric data. It minimizes target function that depends on NMR 
constraints and covalent geometry using molecular dynamics in Cartesian and torsion angle 
space. Restrained molecular dynamics (rMD) often involves simulated annealing method to 
explore the conformational space efficiently. In addition to the theoretical potential energy 
function, penalty functions are added that select against conformations that do not agree with 
experimental data. A conformation with the lowest intrinsic energy is determined that is also 
consistent with the experimental data. NMR structural restraints, NOE, H-bond, torsion angles in 
the correct format are used as input parameters. Initial random coil coordinates and geometric 
protein structure files (PSF), which contain information on protein sequence, molecular bonds, 
bond angles etcetera, are needed. The PDB file of MeCP2 was mutated and used as initial 
structure file for MBD4. The 3D structures are simulated at higher temperature (2000K) using 
molecular dynamics taking forces of the covalent geometry restraints (bond length, bond angles, 
dihedral angles, improper torsions and van der Waals) and experimental restraints (NOE and J 
coupling); NOEs are given stronger force constants than torsion angle restraints. The system is 
then cooled down to 300K with temperature steps of 50K. Energy minimizations in 100 such 
cycles are simulated. At high temperatures, the system is able to occupy high energy regions of 
conformational space and therefore can pass over high energy barriers. This avoids local minima 
and global energy minimum is most likely achieved. In such a way, ensembles of low energy 
structures consistent with the input data are generated. For a high quality structure, more than 10 
distance restraints per residue are used. NOE and torsion angle violations are filtered and 
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removed if needed. More NOE cross-peaks can be assigned based on the initial structure and 
used for refining the structure further. Refined 3D structure has ensemble of structures with 
minimum violations of input restraints and minimum root-mean-square deviation between 
members of the ensemble. A solution structure ensemble of MBD4 was calculated and for 
residues 88 to 140 (avoiding flexible terminal regions) the backbone RMSD of 0.95Å and overall 
RMSD of 1.42Å was seen (Figure 2.4). More iterative assignments of NOEs will result in further 
refinement of the protein structure.   
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4.0 Summary 
The studies presented in this thesis ‘Structural basis of DNA binding complexes’ 
encompass two major aspects of DNA methylation as an epigenetic mark; one that revolves 
around a crucial coiled-coil interaction central to MBD2-mediated silencing and the other that 
describes dynamic behavior of MBD4 in recognizing DNA methylation mark.  
Chapter one: ‘Unique features of the anti-parallel, heterodimeric coiled-coil interaction 
between methyl-cytosine binding domain 2 (MBD2) homologues and p66α dictate high affinity 
binding’ describes the coiled-coil interaction between two proteins (MBD2 and p66α) that is 
critical for DNA methylation dependent gene silencing. Here, we characterized this unique 
interaction and determined the parameters that drive heterodimeric specificity and high affinity 
binding. By comparing MBD2 homologues and their mutation products, we showed a direct 
correlation between helical content of the coiled-coil domains in isolation and binding affinity 
for p66. Importance of maintaining specific ionic interactions and having complementary 
electrostatic surface potentials was demonstrated. This study would help our understanding of 
coiled-coil interactions, which form a common interaction motif in eukaryotic proteins. 
Possessing the knowledge of affinity determinants will facilitate development of small peptide 
based drugs which target such interactions in nature. Additional studies can be performed for 
improving the potency by the cell penetrating peptide by making it more helical, cell-penetrable 
and stable against proteolytic degradation.  
Chapter two: ‘Dynamic behavior of MBD4 in methylated DNA recognition’ included 
studies on MBD4 as a methyl DNA binding protein and its preference for DNA methylation 
mark. Here, we demonstrated that MBD4 can have diverse substrate binding abilities but it 
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prefers mCpG and TpG DNA over hydroxymethylated and unmethylated DNA. Further, with the 
help of chemical exchange studies we showed that MBD4 exchanges slowly on two inter-
molecular DNA binding sites; but on two intra-molecular sites, MBD4 exhibits fast exchange. 
This suggested a facilitated diffusion rather than free 3D diffusion mechanism. Introducing more 
bases or a defect between two intra-molecular sites did not affect the fast exchange rate 
indicating that MBD4 may not always stay in contact with the DNA. This suggested that the 
hopping mechanism of facilitated diffusion was utilized by MBD4. This is the first time we 
demonstrated how MBD domains localize themselves on their cognate DNA binding sites. This 
study can be expanded further to analyze the effects of degree of separation of specific DNA 
binding sites and/or more prominent DNA defects, thereby providing new insights into DNA-
protein recognition. 
Using NMR spectroscopy to elucidate a 3D structure is the focus of chapter three: ‘Solving 
the solution structure of MBD domain of MBD4 on methylated DNA by NMR’. This chapter 
should help with basic workflow used in NMR structure determination.  
I hope this dissertation project summarizing my work with DNA binding complexes 
provide some useful insights into understanding the complex field of epigenetic regulation.  
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